Global Industrial (GIC) 10-K 23 Feb 23 2022 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2022	Feb. 16, 2023	Jun. 30, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	1-13792
Entity Registrant Name	Global Industrial Company
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	11-3262067
Entity Address, Address Line One	11 Harbor Park Drive
Entity Address, City or Town	Port Washington
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11050
City Area Code	(516)
Local Phone Number	608-7000
Title of 12(b) Security	Common Stock, par value $ .01 per share
Trading Symbol	GIC
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 423,761,325
Entity Common Stock, Shares Outstanding		37,966,502
Documents Incorporated by Reference	Portions of the Proxy Statement of Global Industrial Company relating to the Annual Meeting of Stockholders to be held in 2023 are incorporated by reference in Part III hereof.
Entity Central Index Key	0000945114
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2022
Audit Information [Abstract]
Auditor Firm ID	42
Auditor Name	Ernst & Young LLP
Auditor Location	New York, New York

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 28.5	$ 15.4
Accounts receivable, (net of allowance for credit losses of $2.3 and $2.5, respectively)	108	106.8
Inventories	179.4	172.8
Prepaid expenses and other current assets	9.8	6.4
Total current assets	325.7	301.4
Property, plant and equipment, net	21	16.5
Operating lease right-of-use assets	90.3	68.8
Deferred income taxes	9.9	10.3
Goodwill, intangibles and other assets	8.3	8
Total assets	455.2	405
Current liabilities:
Accounts payable	96.9	114.4
Accrued expenses and other current liabilities	43.2	50.5
Short term debt	0.6	4.5
Operating lease liabilities	12.4	10.5
Total current liabilities	153.1	179.9
Operating lease liabilities	89.1	68.5
Other liabilities	2.6	3
Total liabilities	244.8	251.4
Commitments and contingencies
Shareholders’ equity:
Preferred stock, par value $.01 per share, authorized 25 million shares; issued none	0	0
Common stock, par value $0.01 per share, authorized 150 million shares; issued 39,064,239 and 39,011,096 shares; outstanding 37,960,605 and 37,854,409 shares	0.4	0.4
Additional paid-in capital	201.2	195.8
Treasury stock at cost —1,103,634 and 1,156,687 shares	(19.5)	(20.4)
Retained earnings (deficit)	25.9	(25.5)
Accumulated other comprehensive income	2.4	3.3
Total shareholders’ equity	210.4	153.6
Total liabilities and shareholders’ equity	$ 455.2	$ 405

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Allowance for credit loss	$ 2.3	$ 2.5
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	25,000,000	25,000,000
Preferred stock, issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	150,000,000	150,000,000
Common stock, issued (in shares)	39,064,239	39,011,096
Common stock, outstanding (in shares)	37,960,605	37,854,409
Treasury stock at cost (in shares)	1,103,634	1,156,687

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net sales	$ 1,166.1	$ 1,063.1	$ 1,029
Cost of sales	744.9	688.8	672.1
Gross profit	421.2	374.3	356.9
Selling, distribution and administrative expenses	316	286.3	272.8
Operating income from continuing operations	105.2	88	84.1
Foreign currency exchange loss	0.3	0.3	0
Interest and other expense	1.1	0.1	0.1
Income from continuing operations before income taxes	103.8	87.6	84
Provision for income taxes	25.7	17.5	19.9
Net income from continuing operations	78.1	70.1	64.1
Income from discontinued operations, net of tax	0.7	33.2	1.3
Net income	$ 78.8	$ 103.3	$ 65.4
Net income per common share from continuing operations:
Basic (in dollars per share)	$ 2.05	$ 1.85	$ 1.69
Diluted (in dollars per share)	2.04	1.84	1.68
Net income per common share from discontinued operations:
Basic (in dollars per share)	0.02	0.88	0.03
Diluted (in dollars per share)	0.02	0.87	0.03
Net income per common share:
Basic (in dollars per share)	2.07	2.73	1.72
Diluted (in dollars per share)	$ 2.06	$ 2.71	$ 1.71
Weighted average common and common equivalent shares:
Basic (in shares)	38	37.8	37.5
Diluted (in shares)	38.1	38	37.7
Dividends declared (in dollars per share)	$ 0.72	$ 1.64	$ 3.56

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 78.8	$ 103.3	$ 65.4
Other comprehensive income (loss):
Foreign currency translation	(0.9)	(0.1)	0.4
Total comprehensive income	$ 77.9	$ 103.2	$ 65.8

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income from continuing operations	$ 78.1	$ 70.1	$ 64.1
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:
Depreciation and amortization	3.9	3.7	4.1
(Benefit) provision for deferred income taxes	0	(3.2)	(0.5)
Provision for credit losses	1.6	2.8	1.2
Compensation expense related to equity compensation plans	4.5	2.9	4.7
Gain on dispositions and abandonment	(0.1)	0	0
Changes in operating assets and liabilities:
Accounts receivable	(3.3)	(7.4)	(15)
Inventories	(7)	(40.5)	(19.7)
Prepaid expenses and other assets	(1.8)	0.4	(2.6)
Income taxes	(7.1)	3.9	3.1
Accounts payable	(17)	19.7	10.1
Accrued expenses, other current liabilities and other liabilities	(2)	(4.8)	17.8
Net cash provided by operating activities from continuing operations	49.8	47.6	67.3
Net cash provided by operating activities from discontinued operations	0.4	2.2	0.9
Net cash provided by operating activities	50.2	49.8	68.2
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(7.4)	(3.4)	(2.7)
Proceeds from disposals of property, plant and equipment	0.3	0	0
Net cash used in investing activities	(7.1)	(3.4)	(2.7)
CASH FLOWS FROM FINANCING ACTIVITIES:
Dividends paid	(27.6)	(62.5)	(134.3)
Borrowings under credit facility	119	45.2	0
Repayments under credit facility	(122.9)	(40.7)	0
Proceeds from issuance of common stock	0.8	4.9	3.3
Payment of payroll taxes on stock-based compensation through shares withheld	(0.4)	(3)	(1.4)
Proceeds from the issuance of common stock from employee stock purchase plans	1.4	1.1	0.8
Purchase of treasury shares	0	0	(7.2)
Net cash used in financing activities from continuing operations	(29.7)	(55)	(138.8)
EFFECTS OF EXCHANGE RATES ON CASH	(0.3)	0	0.1
NET INCREASE (DECREASE) IN CASH	13.1	(8.6)	(73.2)
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH – BEGINNING OF YEAR	15.4	24	97.2
CASH AND CASH EQUIVALENTS – END OF YEAR	28.5	15.4	24
Supplemental disclosures:
Interest paid	1.2	0.3	0.2
Income taxes paid	32.8	27	17.7
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	34.5	2.6	28.7
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	28.5	15.4	22.4
Restricted cash	0	0	1.6
Total cash, cash equivalents and restricted cash	$ 28.5	$ 15.4	$ 24

CONSOLIDATED STATEMENTS OF SHAR

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Millions	Total	Common Stock	Additional Paid-in Capital	Treasury Stock, At Cost	Retained (Deficit) Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balances (in shares) at Dec. 31, 2019		37,679,000
Beginning balances at Dec. 31, 2019	$ 175.5	$ 0.4	$ 189.7	$ (20.4)	$ 2.8	$ 3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	4.7		4.7
Issuance of restricted stock (in shares)		42,000
Issuance of restricted stock	0		(0.7)	0.7
Stock withheld for employee taxes (in shares)		(47,000)
Stock withheld for employee taxes	(1.4)			(1.4)
Proceeds from issuance of common stock (in shares)		221,000
Proceeds from issuance of common stock	3.3		(1)	4.3
Dividends	$ (134.7)				(134.7)
Purchase of treasury shares (in shares)	(392,337)	(392,000)
Purchase of treasury shares	$ (7.2)			(7.2)
Issuance of shares under employee stock purchase plan (in shares)		49,000
Issuance of shares under employee stock purchase plan	0.8		0.8
Change in cumulative translation adjustment	0.4					0.4
Net income	65.4				65.4
Ending balances (in shares) at Dec. 31, 2020		37,552,000
Ending balances at Dec. 31, 2020	106.8	$ 0.4	193.5	(24)	(66.5)	3.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	2.9		2.9
Issuance of restricted stock (in shares)		78,000
Issuance of restricted stock	0		(1.3)	1.3
Stock withheld for employee taxes (in shares)		(77,000)
Stock withheld for employee taxes	(3)			(3)
Proceeds from issuance of common stock (in shares)		246,000
Proceeds from issuance of common stock	4.9		(0.4)	5.3
Dividends	$ (62.3)				(62.3)
Purchase of treasury shares (in shares)	0
Issuance of shares under employee stock purchase plan (in shares)		55,000
Issuance of shares under employee stock purchase plan	$ 1.1		1.1
Change in cumulative translation adjustment	(0.1)					(0.1)
Net income	$ 103.3				103.3
Ending balances (in shares) at Dec. 31, 2021	37,854,409	37,854,000
Ending balances at Dec. 31, 2021	$ 153.6	$ 0.4	195.8	(20.4)	(25.5)	3.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	4.5		4.5
Issuance of restricted stock (in shares)		32,000
Issuance of restricted stock	0		(0.6)	0.6
Stock withheld for employee taxes (in shares)		(12,000)
Stock withheld for employee taxes	(0.4)			(0.4)
Proceeds from issuance of common stock (in shares)		34,000
Proceeds from issuance of common stock	0.8		0.1	0.7
Dividends	$ (27.4)				(27.4)
Purchase of treasury shares (in shares)	0
Issuance of shares under employee stock purchase plan (in shares)		53,000
Issuance of shares under employee stock purchase plan	$ 1.4		1.4
Change in cumulative translation adjustment	(0.9)					(0.9)
Net income	$ 78.8				78.8
Ending balances (in shares) at Dec. 31, 2022	37,960,605	37,961,000
Ending balances at Dec. 31, 2022	$ 210.4	$ 0.4	$ 201.2	$ (19.5)	$ 25.9	$ 2.4

BASIS OF PRESENTATION

BASIS OF PRESENTATION	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION Global Industrial Company, through its operating subsidiaries, is a value-added industrial distributor of more than one million industrial and maintenance, repair and operation ("MRO") products in North America going to market through a system of branded e-commerce websites and relationship marketers. The Company operates and is internally managed in one reportable business segment. The Company sells a wide array of industrial and maintenance, repair and operation products, markets the Company has served since 1949. Because of the large number of products and product categories the Company offers, providing information on the amount of revenue derived from transactions with external customers for each product or groupings of products is impractical. The Company's discontinued operations include its former North American Technology Group business, which was sold in December 2015 and has been winding down its operations since then. The sale of this business met the “strategic shift with major impact” criteria as defined under Accounting Standards Update ("ASU") 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity , therefore, the results of the former North American Technology business are included in discontinued operations in the accompanying consolidated financial statements. For the years ended December 31, 2022, December 31, 2021 and December 31, 2020, net income from the discontinued North American Technology business totaled $0.7 million, $33.2 million and $1.3 million, respectively. In the fourth quarter of 2021, the Company recorded net income of approximately $22.7 million primarily related to the resolution of certain liabilities of its previously discontinued operations. Related Party Transactions During 2022, the Company incurred a de minimis amount of related party transactions other than those disclosed within the leases disclosure. During 2021, the Company recorded approximately $3.1 million in professional fee expense from a law firm which employs an immediate family member of one of the Company's Vice Chairmen. Amounts outstanding at December 31, 2021 were de minimis and were recorded in Accrued expenses and other current liabilities in the accompanying Consolidated Balance Sheets. During 2020, the Company made inventory purchases of approximately $3.2 million from an entity owned by immediate family members of the Company's Executive Chairman. These transactions were carried out on an arm's length basis and with prior approval of the Company's Nominating and Corporate Governance Committee.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation — The accompanying consolidated financial statements include the accounts of Global Industrial Company, and its wholly-owned subsidiaries (collectively, the “Company” or “Global Industrial”). All significant intercompany accounts and transactions have been eliminated in consolidation. Fiscal Year — The Company’s fiscal year ends at midnight on the Saturday closest to December 31. For clarity of presentation herein, all fiscal years are referred to as if they ended on December 31. The fiscal year is divided into four fiscal quarters that each end at midnight on a Saturday. For clarity of presentation herein, all fiscal quarters are referred to as if they ended on the traditional calendar month. The full year of 2022 and 2021 included 52 weeks, while 2020 included 53 weeks. Use of Estimates in Financial Statements — The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company bases its estimates on historical experience, current business factors, and various other assumptions that the Company believes are necessary to consider to form a basis for making judgments about the carrying values of assets and liabilities, the recorded amounts of revenue and expenses, and the disclosure of contingent assets and liabilities. The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company’s business environment, therefore, actual results could differ from these estimates. Changes in estimates are made when circumstances warrant. Such changes in estimates and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements. Significant estimates and assumptions by management affect the allowance for credit losses, product returns liabilities, inventory reserves, the provision for income taxes and related deferred tax accounts, certain accrued liabilities, revenue recognition, contingencies, litigation and related legal accruals. Foreign Currency Translation — The Company has operations in foreign countries. The functional currency of each foreign country is the local currency. The financial statements of the Company’s foreign entities are translated into U.S. dollars, the reporting currency, using year-end exchange rates for assets and liabilities, year to date average exchange rates for the statement of operations items and historical rates for equity accounts. Translation gains or losses are recorded as a separate component of shareholders’ equity. Cash and cash equivalents — The Company considers amounts held in money market accounts and other short-term investments, including overnight bank deposits, with an original maturity date of three months or less to be cash. Cash overdrafts are classified in accounts payable. Restricted cash — At December 31, 2022 and December 31, 2021, the Company did not have restricted cash. At December 31, 2020, the Company had restricted cash collateralizing letters of credit outstanding of $1.6 million. Amounts included in restricted cash represent those required to be set aside by a contractual agreement with an insurer for the payment of workers' compensation claims. Inventories — Inventories consist primarily of finished goods and are stated at the lower of cost or net realizable value. Cost is determined by using the first-in, first-out method. The Company estimates the net realizable value of its inventory by considering factors such as inventory levels, historical write-off information, market conditions, estimated direct selling costs and physical condition of the inventory as well as credits that we may obtain for returned merchandise. Leases — The Company has operating and finance leases for office and warehouse facilities, headquarters and call centers and certain computer, communications equipment and machinery and equipment which provide the right to use the underlying assets in exchange for agreed upon lease payments, determined by the payment schedule contained in each lease. The Company determines if an arrangement is an operating or finance lease at the inception of the lease. The Company has elected not to apply recognition requirements to leases with terms of one year or less. All other leases are recorded on the balance sheet, with Operating lease right-of-use assets representing the right to use the underlying asset for the lease term and Operating lease liabilities representing the obligation to make lease payments arising from the lease. The ROU assets and corresponding liabilities are recorded based upon the net present value of the lease payments, discounted using interest rates determined by utilizing such factors as the Company's current credit facility terms, length of the lease term, the Company's expected debt credit rating and comparable company term loan yields. Certain leases may include options to extend the lease, however, the Company is not including any impact of such options in the valuation of its ROU assets or liabilities as they are not probable of being extended. The Company's lease agreements do not contain residual value guarantees or restrictive covenants. The Company has sublease agreements for unused space, as well as, excess space in facilities we are currently occupying. The Company’s lease portfolio consists primarily of operating leases which expire at various dates through 2032. Property, Plant and Equipment — Property, plant and equipment is stated at cost. Furniture, fixtures and equipment are depreciated using the straight-line or accelerated method over their estimated useful lives ranging from three years to fifteen years. Leasehold improvements are amortized over the shorter of the useful lives or the term of the respective leases. During 2022, the Company disposed of property, plant and equipment of approximately $3.0 million and accumulated depreciation of approximately $2.9 million. During 2021, the Company disposed of property, plant and equipment of approximately $1.7 million and accumulated depreciation of $1.7 million. Maintenance and repairs are charged to expense as incurred, and improvements are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in the consolidated statement of operations in the period realized. Evaluation of Long-lived Assets — Long-lived assets are assets used in the Company’s operations and include definite-lived intangible assets, leasehold improvements, warehouse and similar property used to generate sales and cash flows. Long-lived assets are tested for impairment utilizing a recoverability test. The recoverability test compares the carrying value of an asset group to the undiscounted cash flows directly attributable to the asset group over the life of the primary asset. If the undiscounted cash flows of an asset group is less than the carrying value of the asset group, the fair value of the asset group is then measured. If the fair value is also determined to be less than the carrying value of the asset group, the asset group is impaired. Goodwill and Intangible Assets — Goodwill represents the excess of the cost of acquired assets over the fair value of assets acquired. The Company operates in one reporting unit and in the fourth quarter of each year performs a quantitative assessment of its goodwill by comparing the Company's fair market value, or market capitalization, to the carrying value of the Company, including goodwill, to determine if impairment exists. Any excess of the carrying amount over fair value would be charged to impairment expense. Income Taxes — The Company accounts for income taxes using the liability method, under which deferred tax assets and liabilities are determined based on the future tax consequences attributable to differences between the financial reporting carrying amounts of existing assets and liabilities and their respective tax basis and tax credit carry forwards and net operating loss carryforwards. Deferred tax assets and liabilities are measured using the enacted tax rates that are expected to be in effect when the differences are expected to reverse. The Company assesses the likelihood that deferred tax assets will be recovered from future taxable income, and a valuation allowance is established when necessary to reduce deferred tax assets to the amounts more likely than not expected to be realized. In accordance with the guidance for accounting for uncertainty in income taxes the Company recognizes the tax benefits from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefit of an uncertain tax position that meets the more-likely-than-not recognition threshold is measured as the largest amount that is greater than 50% likely to be realized upon settlement with the tax authority. To the extent we prevail in matters for which accruals have been established or are required to pay amounts in excess of accruals, our effective tax rate in a given financial statement period could be affected. Revenue Recognition and Accounts Receivable — The Company’s revenue is shown as “Net sales” in the accompanying Consolidated Statements of Operations and is measured as the determined transaction price, net of any variable consideration consisting primarily of rights to return product. The Company has elected to treat shipping and handling revenues as activities to fulfill its performance obligation. Billings for freight and shipping and handling are recorded in net sales and costs of freight and shipping and handling are recorded in cost of sales in the accompanying Consolidated Statements of Operations. The Company will record a contract liability in cases where customers pay in advance of the Company satisfying its performance obligation. The Company did not have any material unsatisfied performance obligations or liabilities as of December 31, 2022 and 2021. The Company offers customers rights to return product within a certain time, usually 30 days. The Company estimates its sales returns liability quarterly based upon its historical return rates as a percentage of historical sales for the trailing twelve-month period. The total accrued sales returns liability was approximately $2.2 million at December 31, 2022 and 2021, respectively, and was recorded as a refund liability in Accrued expenses and other current liabilities in the accompanying Consolidated Balance Sheets. Allowance for Credit Losses — The Company’s trade accounts receivable is one portfolio comprised of commercial businesses and public sector organizations operating in the U.S. and to a much lesser extent, Canada. The Company develops its allowances for credit losses, which represent an estimate of expected losses over the remaining contractual life of its receivables, considering customer financial condition, historical loss experience with its customers, current market economic conditions and forecasts of future economic conditions when appropriate. When the Company becomes aware of a customer's inability to meet its financial obligation, a specific reserve is recorded to reduce the receivable to the expected amount to be collected. For the balance of its trade receivables, the Company uses a loss rate method to estimate its credit loss reserve. Historical loss experience rates are calculated using receivable write offs over a trailing twelve-month period and comparing that to the average receivable balances over the same period. That rate is applied to the current accounts receivable portfolio, excluding accounts that have been specifically reserved. Any write offs incurred are recorded against the established reserves. The Company grants credit to commercial business customers using an electronic application process that evaluates the customer's detailed credit report, reference responses, availability under credit facilities, existing liens, tenure of management and business history, among other factors. Credit terms are typically net 30 days payment required with larger businesses eligible for up to net 90 day terms, if qualified. Shipping and Handling Costs — The Company recognizes shipping and handling costs in cost of sales. Advertising Costs — Expenditures for internet, television, local radio and newspaper advertising are expensed in the period the advertising takes place. Catalog preparation, printing and postage expenditures are amortized over the fiscal year during which the benefits are expected. Net advertising expenses were $72.0 million, $65.3 million and $60.3 million during 2022, 2021 and 2020, respectively, and are included in the accompanying consolidated statements of operations. The Company utilizes advertising programs to drive traffic to its websites, support vendors, including catalogs, internet and magazine advertising, and receives payments and credits from vendors, including consideration pursuant to volume incentive programs and cooperative marketing programs. The Company accounts for consideration from vendors as a reduction of cost of sales unless certain conditions are met showing that the funds are used for specific, incremental, identifiable costs, in which case the consideration is accounted for as a reduction in the related expense category, such as advertising expense. Net Income Per Common Share — Net income per common share - basic is calculated based upon the weighted average number of common shares outstanding during the respective periods presented using the two-class method of computing earnings per share. The two-class method was used as the Company has outstanding restricted stock with rights to dividend participation for unvested shares. Undistributed net income is allocated between common shares outstanding and participating securities to the extent that each security may share in earnings as if all of the earnings for the period had been distributed. Undistributed net losses are not allocated to our participating securities as these participating securities do not have a contractual obligation to share in losses. Net income per common share - diluted was calculated based upon the weighted average number of common shares outstanding and included the equivalent shares for dilutive options outstanding during the respective periods, including unvested options. The dilutive effect of outstanding options and restricted stock issued by the Company is reflected in net income per share - diluted using the treasury stock method. Under the treasury stock method, options will only have a dilutive effect when the average market price of common stock during the period exceeds the exercise price of the options. Employee Benefit Plans — The Company’s U.S. subsidiaries participate in a defined contribution 401(k) plan covering substantially all U.S. employees. Employees may invest 1% or more of their eligible compensation, limited to maximum amounts as determined by the Internal Revenue Service. The Company provides a matching contribution to the plan, determined as a percentage of the employees’ contributions. Aggregate expense to the Company for contributions to the plan was approximately $1.5 million in 2022 and $1.4 million in 2021 and 2020. Fair Value Measurements — Fair value accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value standards establish the fair value hierarchy to prioritize the inputs used in valuation techniques. There are three levels to the fair value hierarchy (Level 1 is the highest priority and Level 3 is the lowest priority): Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 - Inputs other than quoted prices included in Level 1 that are observable for the asset or liability either directly or indirectly. Level 3 - Unobservable inputs which are supported by little or no market activity Financial instruments consist primarily of investments in cash, trade accounts receivable, debt and accounts payable. The Company determines the fair value of financial instruments based on interest rates available to the Company. At December 31, 2022 and 2021, the carrying amounts of cash, accounts receivable, outstanding debt and accounts payable are considered to be representative of their respective fair values due to their short-term nature. Cash is classified as Level 1 within the fair value hierarchy. The fair value of goodwill, non-amortizing intangibles and long-lived assets is measured in connection with the Company’s annual impairment testing as discussed above. The weighted average interest rate on short-term borrowings was 4.4% in 2022, 4.3% in 2021 and 4.4% in 2020. Significant Concentrations — Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and accounts receivable. The Company’s excess cash balances are invested with money center banks. Concentrations of credit risk with respect to accounts receivable are limited due to the large number of customers and their geographic dispersion comprising the Company’s customer base. The Company also performs on-going credit evaluations and maintains allowances for potential losses as warranted. The Company purchases substantially all of its products and components directly from both large and small manufacturers as well as large wholesale distributors. No supplier accounted for 10% or more of our product purchases in 2022, 2021 and 2020. Most private brand products are manufactured by third parties to our specifications. Recent Accounting Pronouncements Public companies in the United States are subject to the accounting and reporting requirements of various authorities, including the Financial Accounting Standards Board (“FASB”) and the Securities and Exchange Commission (“SEC”). These authorities issue numerous pronouncements, most of which are not applicable to the Company’s current or reasonably foreseeable operating structure. There were no accounting pronouncements issued in the year or with future effective dates that are either applicable nor are expected to have a material impact on the Company's Consolidated Financial Statements.

CREDIT LOSSES

CREDIT LOSSES	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
CREDIT LOSSES	CREDIT LOSSES The following is a rollforward of the allowances for credit losses related to the Company's receivables for the year ended December 31, 2022 and 2021 (in millions): December 31, 2022 2021 Balance at beginning of period $ 2.5 $ 1.7 Current period provision 1.6 2.8 Write-offs - trade accounts receivable (1.8) (2.0) Balance at end of period $ 2.3 $ 2.5

LEASES

LEASES	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
LEASES	LEASES The Company has operating and finance leases for office and warehouse facilities, headquarters, call centers, machinery and certain computer and communications equipment which provide the right to use the underlying assets in exchange for agreed upon lease payments, determined by the payment schedule contained in each lease. The Company’s lease portfolio consists primarily of operating leases which expire at various dates through 2032. The Company's operating lease costs, included in continuing operations, was $15.4 million, $13.9 million and $13.1 million, for the years ended December 31, 2022, 2021 and 2020, respectively. Information relating to operating leases for continuing and discontinued operations as of December 31, 2022 and, 2021: Year Ended December 31, 2022 2021 Weighted Average Remaining Lease Term Operating leases 8.2 years 8.1 years Weighted Average Discount Rate Operating leases 5.4 % 5.2 % ROU assets obtained in exchange for operating lease obligations $ 34.5 $ 2.6 Maturities of lease liabilities were as follows (in millions): Year Ending December 31 Operating Leases 2023 $ 17.7 2024 16.7 2025 15.7 2026 13.9 2027 11.7 Thereafter 52.5 Total lease payments 128.2 Less: interest (26.7) Total present value of lease liabilities $ 101.5 The Company currently leases its headquarters office facility from an entity owned by the Company’s principal shareholders. Total rent expense recorded to related parties was $1.0 million in 2022, 2021 and 2020.

REVENUE

REVENUE	12 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
REVENUE	REVENUE Disaggregation of Revenues The Company believes its presentation of revenue by geography most reasonably depicts how the nature, amount, timing and uncertainty of the Company's revenue and cash flows are affected by economic and industry factors, including fluctuations in exchange rates between the U.S. and Canada. The following table presents the Company's revenue, from continuing operations, by geography for the year ended December 31, 2022, 2021 and 2020 (in millions): Year Ended December 31, 2022 2021 2020 Net sales: United States 1,094.3 $ 993.9 $ 968.1 Canada 71.8 69.2 60.9 Consolidated $ 1,166.1 $ 1,063.1 $ 1,029.0

GOODWILL, INTANGIBLES AND OTHER

GOODWILL, INTANGIBLES AND OTHER ASSETS	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL, INTANGIBLES AND OTHER ASSETS	GOODWILL, INTANGIBLES AND OTHER ASSETS The following table provides information related to the carrying value of goodwill, intangibles (indefinite lived and definite lived) and other assets (in millions): December 31, 2022 2021 Goodwill $ 5.5 $ 5.5 Intangibles 1.1 1.3 Other assets 1.7 1.2 Balances, December 31 $ 8.3 $ 8.0 Indefinite-lived intangible assets : The following table provides information related to the carrying value of indefinite lived intangibles as of December 31, 2022 and 2021, respectively (in millions): December 31, 2022 2021 Balance, December 31 $ 0.7 $ 0.7 Definite-lived intangible assets: The following table summarizes information related to definite-lived intangible assets as of December 31, 2022 (in millions): December 31, 2022 Amortization Gross Carrying Accumulated Net Book Value Weighted avg Client lists 5-10 yrs $ 2.0 $ 1.6 $ 0.4 2.1 Domain name 5 yrs 3.4 3.4 0.0 0.0 Total $ 5.4 $ 5.0 $ 0.4 2.1 The following table summarizes information related to definite-lived intangible assets as of December 31, 2021 (in millions): December 31, 2021 Amortization Gross Carrying Accumulated Net Book Value Weighted avg Client lists 5-10 yrs $ 2.0 $ 1.4 $ 0.6 3.1 Domain name 5 yrs 3.4 3.4 0.0 0.0 Total $ 5.4 $ 4.8 $ 0.6 3.1 The aggregate amortization expense for these intangibles was approximately $0.2 million in 2022. The estimated amortization for future years ending December 31 is as follows (in millions): 2023 $ 0.2 2024 0.2 Total $ 0.4

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	12 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
DISCONTINUED OPERATIONS	DISCONTINUED OPERATIONS The Company's discontinued operations include the former North American Technology Group which was sold in December 2015 and has been winding down operations since then (see Note 1). For the year ended December 31, 2022, the Company's discontinued operations recorded net income of approximately $0.7 million primarily related to the classification of restitution receipts of approximately $0.7 million to discontinued operations, offset by related professional fees of approximately $0.4 million and resolution of certain liabilities of these discontinued operations of approximately $0.5 million and recorded approximately $0.2 million for the provision for income taxes. For the year ended December 31, 2021, the Company recorded net income in its discontinued operations of approximately $33.2 million primarily related to the dissolution of certain entities of these previously discontinued operations of $31.7 million, pre-tax, and the classification of approximately $15.0 million in restitution receipts to discontinued operations, offset by $3.0 million of related professional fees and approximately $10.7 million for the provision for income taxes. For the year ended December 31, 2020, the Company's discontinued operations recorded approximately $1.9 million in restitution receipts classified to discontinued operations, offset by approximately $0.5 million of professional fees and $0.5 million for the provision for income taxes. The Company has completed the wind-down activities related to the sale of the France business, as disclosed in previous 10-K filings, but may incur additional charges related to statutory tax and other indemnities given at closing. The Company has substantially completed the wind-down activities related to the former North American Technology Group business, although certain activities related to sublet facilities continue. The net assets and liabilities of discontinued operations are immaterial other than the exit costs disclosure below. The Company expects that total additional exit charges related to discontinued operations after this year may aggregate up to $0.5 million. The following table details liabilities related to the exit costs of the sold businesses that remain for 2022 (in millions): Accrued exit costs Balance January 1, 2022 $ 2.7 Charged to expense 0.1 Paid or otherwise settled (0.4) Balance December 31, 2022 $ 2.4 The following table details liabilities related to the exit costs of the sold businesses for 2021 (in millions): Accrued exit costs Balance, January 1, 2021 $ 2.8 Charged to expense 0.4 Paid or otherwise settled (0.5) Balance, December 31, 2021 $ 2.7

PROPERTY, PLANT AND EQUIPMENT

PROPERTY, PLANT AND EQUIPMENT	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT	PROPERTY, PLANT AND EQUIPMENT Property, plant and equipment, net consist of the following (in millions): December 31, 2022 2021 Land improvements $ 0.8 $ 0.8 Furniture and fixtures, office, computer and other equipment and software 42.4 37.8 Leasehold improvements 14.2 13.5 57.4 52.1 Less accumulated depreciation and amortization 36.4 35.6 Property, plant and equipment, net $ 21.0 $ 16.5

CREDIT FACILITIES AND SHORT-TER

CREDIT FACILITIES AND SHORT-TERM DEBT	12 Months Ended
	Dec. 31, 2022
Line of Credit Facility [Abstract]
CREDIT FACILITIES AND SHORT-TERM DEBT	CREDIT FACILITIES AND SHORT-TERM DEBTIn November 2022, the Company amended its credit agreement to increase its existing $75 million secured revolving credit facility to $125 million. This credit facility is with one financial institution, which provides for borrowings in the United States and has a five-year term, maturing on October 19, 2026. The credit agreement contains certain operating, financial and other covenants, including limits on annual levels of capital expenditures, availability tests related to payments of dividends and stock repurchases and fixed charge coverage tests related to acquisitions.  The revolving credit agreement requires that a minimum level of availability be maintained. If such availability is not maintained, the Company will be required to maintain a fixed charge coverage ratio (as defined).  The borrowings under the agreement are subject to borrowing base limitations of up to 85% of eligible accounts receivable and the inventory advance rate computed as the lesser of 65% (previously 60%) or 85% of the net orderly liquidation value (“NOLV”).   Borrowings are secured by substantially all of the borrower’s assets, as defined, including all accounts, accounts receivable, inventory and certain other assets, subject to limited exceptions, including the exclusion of certain foreign assets from the collateral.  The interest rate under the amended and restated facility is computed at applicable market rates based on the Secured Overnight Financing Rate ("SOFR"), the Federal Reserve Bank of New York (“NYFRB”) or the Prime Rate, plus an applicable margin. The applicable margin varies based on borrowing base availability.  As of December 31, 2022, eligible collateral under the credit agreement was $116.4 million, total availability was $113.7 million, total outstanding letters of credit was $1.4 million, total outstanding borrowings was $0.6 million and total excess availability was $111.7 million. The Company was in compliance with all of the covenants of the credit agreement in place as of December 31, 2022.

ACCRUED EXPENSES AND OTHER CURR

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	12 Months Ended
	Dec. 31, 2022
Payables and Accruals [Abstract]
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Accrued expenses and other current liabilities consist of the following (in millions): December 31, 2022 2021 Payroll and employee benefits $ 22.5 $ 22.3 Sales and VAT tax payable 2.9 2.8 Freight 7.7 11.4 Income taxes payable 0.0 4.9 Product returns liability 2.2 2.2 Other 7.9 6.9 $ 43.2 $ 50.5

NET INCOME PER COMMON SHARE

NET INCOME PER COMMON SHARE	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
NET INCOME PER COMMON SHARE	NET INCOME PER COMMON SHARE Net income per common share - basic was calculated based upon the weighted average number of common shares outstanding during the respective periods presented using the two-class method of computing earnings per share. The two-class method was used as the Company has outstanding restricted stock with rights to dividend participation for unvested shares. Undistributed net income is allocated between common shares outstanding and participating securities to the extent that each security may share in earnings as if all of the earnings for the period had been distributed. Undistributed net losses are not allocated to our participating securities as these participating securities do not have a contractual obligation to share in losses. Net income per common share - diluted was calculated based upon the weighted average number of common shares outstanding and included the equivalent shares for dilutive options outstanding during the respective periods, including unvested options. The dilutive effect of outstanding options and restricted stock issued by the Company is reflected in net income per share - diluted using the treasury stock method. Under the treasury stock method, options will only have a dilutive effect when the average market price of common stock during the period exceeds the exercise price of the options. The following table presents the computation of basic and diluted net income per share under the two-class method for the year ended December 31, 2022, 2021 ad 2020 (in millions, except for per share amounts): Year Ended December 31, 2022 2021 2020 Net income from continuing operations $ 78.1 $ 70.1 $ 64.1 Less: Distributed net income available to participating securities (0.1) (0.3) (0.8) Less: Undistributed net income available to participating securities (0.2) 0.0 0.0 Numerator for basic net income per share: Undistributed and distributed net income available to common shareholders $ 77.8 $ 69.8 $ 63.3 Add: Undistributed net income allocated to participating securities 0.2 0.0 0.0 Less: Undistributed net income reallocated to participating securities (0.2) 0.0 0.0 Numerator for diluted net income per share: Undistributed and distributed net income available to common shareholders $ 77.8 $ 69.8 $ 63.3 Denominator: Weighted average shares outstanding for basic net income per share 38.0 37.8 37.5 Effect of dilutive securities 0.1 0.2 0.2 Weighted average shares outstanding for diluted net income per share 38.1 38.0 37.7 Net income per share from continuing operations: Basic $ 2.05 $ 1.85 $ 1.69 Diluted $ 2.04 $ 1.84 $ 1.68 Net income from discontinued operations $ 0.7 $ 33.2 $ 1.3 Less: Distributed net income available to participating securities $ 0.0 $ 0.0 $ 0.0 Less: Undistributed net income available to participating securities $ 0.0 $ (0.2) $ 0.0 Numerator for basic net income per share: Undistributed and distributed net income available to common shareholders $ 0.7 $ 33.0 $ 1.3 Add: Undistributed net income allocated to participating securities $ 0.0 $ 0.2 $ 0.0 Less: Undistributed net income reallocated to participating securities $ 0.0 $ (0.2) $ 0.0 Numerator for diluted net income per share: Undistributed and distributed net income available to common shareholders $ 0.7 $ 33.0 $ 1.3 Net income per share from discontinued operations: Basic $ 0.02 $ 0.88 $ 0.03 Diluted $ 0.02 $ 0.87 $ 0.03 Net income per share: Basic $ 2.07 $ 2.73 $ 1.72 Diluted $ 2.06 $ 2.71 $ 1.71 Potentially dilutive securities 0.1 0.1 0.5 Potentially dilutive securities attributable to outstanding stock options, restricted stock units, and performance share units excluded from the calculation of diluted earnings per share where the combined exercise price and average unamortized fair value are greater than the average market price of Global Industrial Company's common stock, and their inclusion would be anti-dilutive.

STOCK REPURCHASES

STOCK REPURCHASES	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
STOCK REPURCHASES	STOCK REPURCHASESIn 2018, the Company's Board of Director's approved a share repurchase program with a repurchase authorization of up to two million shares of the Company's common stock. During 2022 and 2021, no shares were repurchased. In 2020, the Company repurchased 392,337 common shares for approximately $7.2 million. The maximum number of shares that may yet be purchased under the Plan was approximately 1,375,000 at December 31, 2022.SHAREHOLDERS’ EQUITY Stock-Based Compensation Plans The Company currently has two equity compensation plans which reserve shares of common stock for issuance to key employees, directors, consultants and advisors to the Company. The following is a description of these plans: The 2010 Long-term Stock Incentive Plan (“2010 Plan”) - This plan was adopted in April 2010 and allows the Company to issue incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock and restricted stock units, performance awards and other stock based awards authorized by the Compensation Committee of the Board of Directors. Options and awards issued under this plan expire ten years after the options and awards are granted. The maximum number of shares granted per type of award to any individual may not exceed 1,500,000 in any calendar year. Restricted stock grants and common stock awards reduce stock options otherwise available for future grant. Awards for a maximum of 7,500,000 shares may be granted under this plan. The Company is no longer granting options or awards under this plan. A total of 339,856 options and 30,323 restricted stock units were outstanding under this plan as of December 31, 2022. The 2020 Omnibus Stock Incentive Plan (“2020 Omnibus Plan”) - This plan was adopted in June 2020 and allows the Company to issue incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock based awards authorized by the Compensation Committee of the Board of Directors. Options and awards issued under this plan expire ten years after the options and awards are granted. The maximum number of shares granted per type of award to any individual may not exceed 1,500,000 in any calendar year (or $10.0 million in the case of cash performance awards). Restricted stock grants and common stock awards reduce stock options otherwise available for future grant. Awards for a maximum of 7,500,000 shares may be granted under this plan. A total of 169,356 options and 118,902 restricted stock units were outstanding under this plan as of December 31, 2022. The fair value of employee share options is recognized in expense over the vesting period of the options, using the graded attribution method. The fair value of employee share options is determined on the date of grant using the Black-Scholes option pricing model. The Company has calculated its dividend yield by dividing the annualized regular quarterly dividend by the current stock price at grant date. The Company has used historical volatility in its estimate of expected volatility. The expected life represents the period of time (in years) for which the options granted are expected to be outstanding. The risk-free interest rate is based on the U.S. Treasury yield curve. Stock-based compensation expense includes an estimate for forfeitures and is recognized over the expected term of the award. The fair value of the restricted stock ("RSU") and performance restricted stock ("PRSU") is the closing stock price on the NYSE of the Company's common stock on the date of grant or the closing stock price of the Company's common stock on the last business day prior to the grant date. Upon delivery, a portion of the RSU or PRSU award may be withheld to satisfy the statutory withholding taxes. The remaining RSU's or PRSU's will be settled in shares of the Company's common stock after the vesting period and on the prescribed delivery date. These RSUs and PRSU's have none of the rights of outstanding shares of common stock, other than rights to cash dividends, until common stock is distributed. Shares issued under our share-based compensation plans are usually issued from shares of our common stock held in the treasury. Compensation cost related to non-qualified stock options recognized in continuing operations (selling, distribution and administrative expenses) for 2022, 2021 and 2020 was $1.3 million, $1.1 million, and $1.8 million respectively. The related future income tax benefits recognized for 2022, 2021 and 2020 were $0.2 million, $0.3 million and $0.4 million, respectively. Stock Options The following table presents the weighted-average assumptions used to estimate the fair value of options granted in 2022, 2021 and 2020: 2022 2021 2020 Expected annual dividend yield 2.0 % 1.4 % 2.0 % Risk-free interest rate 1.85 % 0.75 % 1.38 % Expected volatility 52.8 % 51.9 % 51.1 % Expected life in years 5.0 5.0 5.2 The following table summarizes information concerning outstanding and exercisable options: Weighted Average 2022 2021 2020 Shares Weighted Shares Weighted Shares Weighted Outstanding at beginning of year 463,304 $ 24.28 661,024 $ 19.78 764,784 $ 17.31 Granted 79,025 $ 32.65 110,112 $ 38.02 111,872 $ 23.60 Exercised (29,917) $ 22.87 (196,639) $ 15.37 (191,780) $ 11.68 Canceled or expired (3,200) $ 26.61 (111,193) $ 26.87 (23,852) $ 23.71 Outstanding at end of year 509,212 $ 25.65 463,304 $ 24.28 661,024 $ 19.78 Options exercisable at year end 297,889 223,158 302,283 Weighted average fair value per option granted during the year $ 13.07 $ 18.50 $ 9.12 The total intrinsic value of options exercised was $0.3 million in 2022, $4.5 million in 2021 and $3.9 million in 2020. The following table summarizes information about options vested and exercisable or non-vested that are expected to vest (non-vested outstanding less expected forfeitures) at December 31, 2022: Range of Exercise Prices Options Outstanding and Weighted Weighted Average Aggregate $ 5.00 to $ 15.00 47,500 $ 5.92 3.65 $ 0.8 $ 15.01 to $ 25.00 319,572 $ 23.55 6.19 0.1 $ 25.01 to $ 35.00 87,439 $ 32.75 9.05 0.0 $ 35.01 to $ 45.00 54,701 $ 43.68 8.23 0.0 $ 5.00 to $ 45.00 509,212 $ 25.65 6.67 $ 0.9 The aggregate intrinsic value in the tables above represents the total pretax intrinsic value (the difference between the closing stock price on the last day of trading in 2022 and the exercise price) that would have been received by the option holders had all options been exercised on December 31, 2022. This value will change based on the fair market value of the Company’s common stock. The following table reflects the activity for all unvested stock options during 2022: Shares Weighted Unvested at January 1, 2022 240,146 $ 12.80 Granted 79,025 $ 13.07 Vested (104,711) $ 11.26 Forfeited (3,137) $ 26.26 Unvested at December 31, 2022 211,323 $ 12.84 At December 31, 2022, there was approximately $1.1 million of unrecognized compensation costs related to unvested stock options, which is expected to be recognized over a weighted average period of 2.88 years. The total fair value of stock options vested during 2022, 2021 and 2020 was $1.3 million, $1.2 million and $2.5 million, respectively. Restricted Stock and Restricted Stock Units The following table reflects the activity for restricted stock awards, excluding the restricted stock issued to Directors (in millions, except shares data): Year Granted Shares Granted Outstanding at December 31, 2022 Rights to Cash Dividend Other Participation Rights Performance Award Compensation Expense Year Ended December 31, 2022 2021 2020 2019 30,251 12,100 Yes None No 0.1 0.1 0.2 2019 149,412 0 Yes None Yes 0.3 0.1 1.2 2020 28,272 14,136 Yes None No 0.1 0.2 0.4 2020 43,330 4,087 Yes None Yes 0.1 0.1 0.6 2021 25,371 19,028 Yes None No 0.3 0.4 0.0 2021 32,874 9,795 Yes None Yes 0.2 0.3 0.0 2022 60,808 54,807 Yes None No 0.8 0.0 0.0 2022 32,875 23,360 Yes None Yes 0.6 0.0 0.0 Total $ 2.5 $ 1.2 $ 2.4 Share-based compensation expense reported within continuing operations for restricted stock issued to Directors was $0.2 million in 2022, 2021 and 2020, respectively, and is recorded within selling, distribution and administrative expenses. A total of 5,996 shares were granted to Directors during 2022 and a total of 11,912 restricted stock units from the 2020 Omnibus Plan are outstanding to the Directors as of December 31, 2022. At December 31, 2022, there was approximately $2.5 million of unrecognized compensation cost related to the unvested RSU's, which is expected to be recognized over a weighted average period of 2.88 years. Total compensation expense related to RSU and performance RSU's reported within continuing operations was approximately $2.7 million, $1.4 million and $2.5 million for the years ended December 31, 2022, 2021 and 2020, respectively, and is recorded within selling, distribution and administrative expenses. The following table reflects the activity for all unvested restricted stock during 2022: Shares Weighted Unvested at January 1, 2022 135,446 $ 28.48 Granted 99,679 $ 34.14 Vested (84,483) $ 26.79 Forfeited (1,417) $ 26.10 Unvested at December 31, 2022 149,225 $ 33.24 Employee Stock Purchase Plan

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
SHAREHOLDERS' EQUITY	STOCK REPURCHASESIn 2018, the Company's Board of Director's approved a share repurchase program with a repurchase authorization of up to two million shares of the Company's common stock. During 2022 and 2021, no shares were repurchased. In 2020, the Company repurchased 392,337 common shares for approximately $7.2 million. The maximum number of shares that may yet be purchased under the Plan was approximately 1,375,000 at December 31, 2022.SHAREHOLDERS’ EQUITY Stock-Based Compensation Plans The Company currently has two equity compensation plans which reserve shares of common stock for issuance to key employees, directors, consultants and advisors to the Company. The following is a description of these plans: The 2010 Long-term Stock Incentive Plan (“2010 Plan”) - This plan was adopted in April 2010 and allows the Company to issue incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock and restricted stock units, performance awards and other stock based awards authorized by the Compensation Committee of the Board of Directors. Options and awards issued under this plan expire ten years after the options and awards are granted. The maximum number of shares granted per type of award to any individual may not exceed 1,500,000 in any calendar year. Restricted stock grants and common stock awards reduce stock options otherwise available for future grant. Awards for a maximum of 7,500,000 shares may be granted under this plan. The Company is no longer granting options or awards under this plan. A total of 339,856 options and 30,323 restricted stock units were outstanding under this plan as of December 31, 2022. The 2020 Omnibus Stock Incentive Plan (“2020 Omnibus Plan”) - This plan was adopted in June 2020 and allows the Company to issue incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock based awards authorized by the Compensation Committee of the Board of Directors. Options and awards issued under this plan expire ten years after the options and awards are granted. The maximum number of shares granted per type of award to any individual may not exceed 1,500,000 in any calendar year (or $10.0 million in the case of cash performance awards). Restricted stock grants and common stock awards reduce stock options otherwise available for future grant. Awards for a maximum of 7,500,000 shares may be granted under this plan. A total of 169,356 options and 118,902 restricted stock units were outstanding under this plan as of December 31, 2022. The fair value of employee share options is recognized in expense over the vesting period of the options, using the graded attribution method. The fair value of employee share options is determined on the date of grant using the Black-Scholes option pricing model. The Company has calculated its dividend yield by dividing the annualized regular quarterly dividend by the current stock price at grant date. The Company has used historical volatility in its estimate of expected volatility. The expected life represents the period of time (in years) for which the options granted are expected to be outstanding. The risk-free interest rate is based on the U.S. Treasury yield curve. Stock-based compensation expense includes an estimate for forfeitures and is recognized over the expected term of the award. The fair value of the restricted stock ("RSU") and performance restricted stock ("PRSU") is the closing stock price on the NYSE of the Company's common stock on the date of grant or the closing stock price of the Company's common stock on the last business day prior to the grant date. Upon delivery, a portion of the RSU or PRSU award may be withheld to satisfy the statutory withholding taxes. The remaining RSU's or PRSU's will be settled in shares of the Company's common stock after the vesting period and on the prescribed delivery date. These RSUs and PRSU's have none of the rights of outstanding shares of common stock, other than rights to cash dividends, until common stock is distributed. Shares issued under our share-based compensation plans are usually issued from shares of our common stock held in the treasury. Compensation cost related to non-qualified stock options recognized in continuing operations (selling, distribution and administrative expenses) for 2022, 2021 and 2020 was $1.3 million, $1.1 million, and $1.8 million respectively. The related future income tax benefits recognized for 2022, 2021 and 2020 were $0.2 million, $0.3 million and $0.4 million, respectively. Stock Options The following table presents the weighted-average assumptions used to estimate the fair value of options granted in 2022, 2021 and 2020: 2022 2021 2020 Expected annual dividend yield 2.0 % 1.4 % 2.0 % Risk-free interest rate 1.85 % 0.75 % 1.38 % Expected volatility 52.8 % 51.9 % 51.1 % Expected life in years 5.0 5.0 5.2 The following table summarizes information concerning outstanding and exercisable options: Weighted Average 2022 2021 2020 Shares Weighted Shares Weighted Shares Weighted Outstanding at beginning of year 463,304 $ 24.28 661,024 $ 19.78 764,784 $ 17.31 Granted 79,025 $ 32.65 110,112 $ 38.02 111,872 $ 23.60 Exercised (29,917) $ 22.87 (196,639) $ 15.37 (191,780) $ 11.68 Canceled or expired (3,200) $ 26.61 (111,193) $ 26.87 (23,852) $ 23.71 Outstanding at end of year 509,212 $ 25.65 463,304 $ 24.28 661,024 $ 19.78 Options exercisable at year end 297,889 223,158 302,283 Weighted average fair value per option granted during the year $ 13.07 $ 18.50 $ 9.12 The total intrinsic value of options exercised was $0.3 million in 2022, $4.5 million in 2021 and $3.9 million in 2020. The following table summarizes information about options vested and exercisable or non-vested that are expected to vest (non-vested outstanding less expected forfeitures) at December 31, 2022: Range of Exercise Prices Options Outstanding and Weighted Weighted Average Aggregate $ 5.00 to $ 15.00 47,500 $ 5.92 3.65 $ 0.8 $ 15.01 to $ 25.00 319,572 $ 23.55 6.19 0.1 $ 25.01 to $ 35.00 87,439 $ 32.75 9.05 0.0 $ 35.01 to $ 45.00 54,701 $ 43.68 8.23 0.0 $ 5.00 to $ 45.00 509,212 $ 25.65 6.67 $ 0.9 The aggregate intrinsic value in the tables above represents the total pretax intrinsic value (the difference between the closing stock price on the last day of trading in 2022 and the exercise price) that would have been received by the option holders had all options been exercised on December 31, 2022. This value will change based on the fair market value of the Company’s common stock. The following table reflects the activity for all unvested stock options during 2022: Shares Weighted Unvested at January 1, 2022 240,146 $ 12.80 Granted 79,025 $ 13.07 Vested (104,711) $ 11.26 Forfeited (3,137) $ 26.26 Unvested at December 31, 2022 211,323 $ 12.84 At December 31, 2022, there was approximately $1.1 million of unrecognized compensation costs related to unvested stock options, which is expected to be recognized over a weighted average period of 2.88 years. The total fair value of stock options vested during 2022, 2021 and 2020 was $1.3 million, $1.2 million and $2.5 million, respectively. Restricted Stock and Restricted Stock Units The following table reflects the activity for restricted stock awards, excluding the restricted stock issued to Directors (in millions, except shares data): Year Granted Shares Granted Outstanding at December 31, 2022 Rights to Cash Dividend Other Participation Rights Performance Award Compensation Expense Year Ended December 31, 2022 2021 2020 2019 30,251 12,100 Yes None No 0.1 0.1 0.2 2019 149,412 0 Yes None Yes 0.3 0.1 1.2 2020 28,272 14,136 Yes None No 0.1 0.2 0.4 2020 43,330 4,087 Yes None Yes 0.1 0.1 0.6 2021 25,371 19,028 Yes None No 0.3 0.4 0.0 2021 32,874 9,795 Yes None Yes 0.2 0.3 0.0 2022 60,808 54,807 Yes None No 0.8 0.0 0.0 2022 32,875 23,360 Yes None Yes 0.6 0.0 0.0 Total $ 2.5 $ 1.2 $ 2.4 Share-based compensation expense reported within continuing operations for restricted stock issued to Directors was $0.2 million in 2022, 2021 and 2020, respectively, and is recorded within selling, distribution and administrative expenses. A total of 5,996 shares were granted to Directors during 2022 and a total of 11,912 restricted stock units from the 2020 Omnibus Plan are outstanding to the Directors as of December 31, 2022. At December 31, 2022, there was approximately $2.5 million of unrecognized compensation cost related to the unvested RSU's, which is expected to be recognized over a weighted average period of 2.88 years. Total compensation expense related to RSU and performance RSU's reported within continuing operations was approximately $2.7 million, $1.4 million and $2.5 million for the years ended December 31, 2022, 2021 and 2020, respectively, and is recorded within selling, distribution and administrative expenses. The following table reflects the activity for all unvested restricted stock during 2022: Shares Weighted Unvested at January 1, 2022 135,446 $ 28.48 Granted 99,679 $ 34.14 Vested (84,483) $ 26.79 Forfeited (1,417) $ 26.10 Unvested at December 31, 2022 149,225 $ 33.24 Employee Stock Purchase Plan

INCOME TAX

INCOME TAX	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
INCOME TAX	INCOME TAX The following table summarizes our U.S. and foreign components of income from continuing operations before income taxes (in millions): Year Ended December 31, 2022 2021 2020 United States $ 104.0 $ 84.5 $ 80.5 Foreign (0.2) 3.1 3.5 Total $ 103.8 $ 87.6 $ 84.0 The following table summarizes the (benefit) provision for income taxes from continuing operations (in millions): Year Ended December 31, 2022 2021 2020 Current: Federal $ 21.2 $ 16.8 $ 17.0 State 4.3 3.8 3.3 Foreign 0.2 0.1 0.1 Total current $ 25.7 $ 20.7 $ 20.4 Deferred: Federal $ 0.0 $ (0.6) $ (0.8) State 0.1 (0.2) 0.3 Foreign (0.1) (2.4) 0.0 Total deferred $ 0.0 $ (3.2) $ (0.5) Total tax provision $ 25.7 $ 17.5 $ 19.9 Tax expense from discontinued operations was $0.2 million, $10.7 million and $0.5 million for the years ended December 31, 2022, 2021 and 2020, respectively. Income taxes are accrued and paid by each foreign entity in accordance with applicable local regulations. A reconciliation of the difference between the income tax expense and the computed income tax expense from continuing operations based on the Federal statutory corporate rate is as follows (in millions): Year Ended December 31, 2022 2021 2020 Income tax at Federal statutory rate $ 21.8 21.0 % $ 18.4 21.0 % $ 17.6 21.0 % State and local income taxes, net of federal tax benefit 3.7 3.7 % 2.9 3.3 % 3.0 3.5 % Reversal of valuation allowances 0.0 0.0 % (3.4) (3.8) % (0.9) (1.0) % 2017 TCJA, net deferred tax remeasurement and repatriation tax impacts (0.2) (0.1) % 0.0 0.0 % 0.0 0.0 % Stock based compensation 0.0 0.0 % (0.8) (0.9) % (0.5) (0.6) % Non-deductible items 0.7 0.6 % 0.5 0.5 % 0.8 0.9 % Other items, net (0.3) (0.4) % (0.1) (0.1) % (0.1) (0.1) % Income tax $ 25.7 24.8 % $ 17.5 20.0 % $ 19.9 23.7 % The deferred tax assets and liabilities are comprised of the following (in millions): December 31, 2022 2021 Assets: Accrued expenses and other liabilities $ 1.6 $ 2.4 Inventory 2.9 2.8 Operating lease obligations 25.3 18.8 Intangible & other 0.4 0.0 Net operating loss and credit carryforwards 8.1 8.8 Valuation allowances (5.8) (6.1) Total deferred tax assets $ 32.5 $ 26.7 Liabilities: Operating lease right-of-use assets $ 22.6 $ 16.4 Other 0.1 0.2 Total deferred tax liabilities $ 22.7 $ 16.6 The following table summarizes the changes in valuation allowance (in millions): Balance at Benefit Recognized in Expense Write-offs Other Balance at 2022 $ (6.1) $ 0.0 $ 0.3 $ 0.0 $ (5.8) 2021 $ (15.2) $ 3.0 $ 7.0 $ (0.9) $ (6.1) During 2022 the Company utilized approximately $0.4 million in state NOL carryforwards to reduce the current year tax expense. As of December 31, 2022, the Company has foreign tax credits and NOLs of $6.9 million which expire through 2034 and foreign tax credit carryforwards of $0.6 million expiring in years through 2029. The Company has recorded valuation allowances of approximately $5.8 million, including valuations against foreign NOLs of $5.2 million and $0.6 million against foreign tax carryforwards. Valuation allowances have been recorded against these assets as the Company believes it is more likely than not that these NOLs, temporary differences and foreign tax credits will not be utilized in the near future. The Company has not provided for federal income taxes applicable to the undistributed earnings of its foreign subsidiaries, primarily in India and Canada, of approximately $0.4 million as of December 31, 2022, since these earnings are considered permanently reinvested in the subsidiaries. The Company's permanent reinvestment assertion has not changed following the enactment of the TCJA. If the Company ceases to be permanently reinvested in its foreign subsidiaries, the Company may be subject to foreign withholding and other taxes on undistributed earnings and may need to record a deferred tax liability for any outside basis difference in its investments in its foreign subsidiaries. Under the TCJA each U.S. shareholder of a controlled foreign corporation ("CFC") must include in its gross taxable income in any tax year the aggregate net GILTI, or net income, of its CFCs. In 2022 the Company has included in taxable income the net income of its subsidiaries in the Netherlands, India, and Canada. The Company has elected to treat GILTI expense as a period cost when incurred. The Company is routinely audited by federal, state and foreign tax authorities with respect to its income taxes. The Company regularly reviews and evaluates the likelihood of audit assessments. The Company’s federal income tax returns have been audited through 2016. The Company has not signed any consent to extend the statute of limitations for any subsequent years. The Company’s significant state tax returns have been audited through 2016. The Company considers its significant tax jurisdictions in foreign locations to be Canada and India. As of December 31, 2022, the Company had no uncertain tax positions. Interest and penalties, if any, are recorded in income tax expense. There were no accrued interest or penalty charges related to unrecognized tax benefits recorded in income tax expense in 2022, 2021 or 2020.

COMMITMENTS, CONTINGENCIES AND

COMMITMENTS, CONTINGENCIES AND OTHER MATTERS	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS, CONTINGENCIES AND OTHER MATTERS	COMMITMENTS, CONTINGENCIES AND OTHER MATTERS The Company and its subsidiaries are from time to time involved in various lawsuits, claims, investigations and proceedings which may include commercial, employment, tax, customs and trade, customer, vendor, personal injury, creditors rights and health and safety law matters, which are handled and defended in the ordinary course of business. In addition, the Company is from time to time subjected to various assertions, claims, proceedings and requests for damages and/or indemnification concerning sales channel practices and intellectual property matters, including patent infringement suits involving technologies that are incorporated in a broad spectrum of products the Company sells or that are incorporated in the Company’s e-commerce sales channels, as well as trademark/copyright infringement claims. The Company is also audited by (or has initiated voluntary disclosure agreements with) various U.S. Federal and state authorities, as well as Canadian authorities, concerning potential income tax and/or sales tax. These matters are in various stages of investigation, negotiation and/or litigation. The Company intends to vigorously defend these matters and believes it has strong defenses. Although the Company does not expect, based on currently available information, that the outcome in any of these matters, individually or collectively, will have a material adverse effect on its financial position or results of operations, the ultimate outcome is inherently unpredictable. Therefore, judgments could be rendered or settlements entered, that could adversely affect the Company’s operating results or cash flows in a particular period. The Company regularly assesses all of its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable and estimable. In this regard, the Company establishes accrual estimates for its various lawsuits, claims, investigations and proceedings when it is probable that an asset has been impaired or a liability incurred at the date of the financial statements and the loss can be reasonably estimated. At December 31, 2022 the Company has established accruals for certain of its various lawsuits, claims, investigations and proceedings based upon estimates of the most likely outcome in a range of loss or the minimum amounts in a range of loss if no amount within a range is a more likely estimate. The Company does not believe that at December 31, 2022 any reasonably possible losses in excess of the amounts accrued would be material to the financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation — The accompanying consolidated financial statements include the accounts of Global Industrial Company, and its wholly-owned subsidiaries (collectively, the “Company” or “Global Industrial”). All significant intercompany accounts and transactions have been eliminated in consolidation.
Fiscal Year	Fiscal Year — The Company’s fiscal year ends at midnight on the Saturday closest to December 31. For clarity of presentation herein, all fiscal years are referred to as if they ended on December 31. The fiscal year is divided into four fiscal quarters that each end at midnight on a Saturday. For clarity of presentation herein, all fiscal quarters are referred to as if they ended on the traditional calendar month. The full year of 2022 and 2021 included 52 weeks, while 2020 included 53 weeks.
Use of Estimates In Financial Statements	Use of Estimates in Financial Statements — The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company bases its estimates on historical experience, current business factors, and various other assumptions that the Company believes are necessary to consider to form a basis for making judgments about the carrying values of assets and liabilities, the recorded amounts of revenue and expenses, and the disclosure of contingent assets and liabilities. The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company’s business environment, therefore, actual results could differ from these estimates. Changes in estimates are made when circumstances warrant. Such changes in estimates and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements. Significant estimates and assumptions by management affect the allowance
Foreign Currency Translation	Foreign Currency Translation — The Company has operations in foreign countries. The functional currency of each foreign country is the local currency. The financial statements of the Company’s foreign entities are translated into U.S. dollars, the reporting currency, using year-end exchange rates for assets and liabilities, year to date average exchange rates for the statement of operations items and historical rates for equity accounts. Translation gains or losses are recorded as a separate component of shareholders’ equity.
Cash and cash equivalents	Cash and cash equivalents — The Company considers amounts held in money market accounts and other short-term investments, including overnight bank deposits, with an original maturity date of three months or less to be cash. Cash overdrafts are classified in accounts payable.
Restricted cash	Restricted cash
Inventories	Inventories — Inventories consist primarily of finished goods and are stated at the lower of cost or net realizable value. Cost is determined by using the first-in, first-out method. The Company estimates the net realizable value of its inventory by considering factors such as inventory levels, historical write-off information, market conditions, estimated direct selling costs and physical condition of the inventory as well as credits that we may obtain for returned merchandise.
Leases	Leases — The Company has operating and finance leases for office and warehouse facilities, headquarters and call centers and certain computer, communications equipment and machinery and equipment which provide the right to use the underlying assets in exchange for agreed upon lease payments, determined by the payment schedule contained in each lease. The Company determines if an arrangement is an operating or finance lease at the inception of the lease. The Company has elected not to apply recognition requirements to leases with terms of one year or less. All other leases are recorded on the balance sheet, with Operating lease right-of-use assets representing the right to use the underlying asset for the lease term and Operating lease liabilities representing the obligation to make lease payments arising from the lease. The ROU assets and corresponding liabilities are recorded based upon the net present value of the lease payments, discounted using interest rates determined by utilizing such factors as the Company's current credit facility terms, length of the lease term, the Company's expected debt credit rating and comparable company term loan yields. Certain leases may include options to extend the lease, however, the Company is not including any impact of such options in the valuation of its ROU assets or liabilities as they are not probable of being extended. The Company's lease agreements do not contain residual value guarantees or restrictive covenants. The Company has sublease agreements for unused space, as well as, excess space in facilities we are currently occupying.
Property, Plant and Equipment	Property, Plant and Equipment — Property, plant and equipment is stated at cost. Furniture, fixtures and equipment are depreciated using the straight-line or accelerated method over their estimated useful lives ranging from three years to fifteen years. Leasehold improvements are amortized over the shorter of the useful lives or the term of the respective leases.
Evaluation of Long-lived Assets	Evaluation of Long-lived Assets — Long-lived assets are assets used in the Company’s operations and include definite-lived intangible assets, leasehold improvements, warehouse and similar property used to generate sales and cash flows. Long-lived assets are tested for impairment utilizing a recoverability test. The recoverability test compares the carrying value of an asset group to the undiscounted cash flows directly attributable to the asset group over the life of the primary asset. If the undiscounted cash flows of an asset group is less than the carrying value of the asset group, the fair value of the asset group is then measured. If the fair value is also determined to be less than the carrying value of the asset group, the asset group is impaired.
Goodwill and Intangible Assets	Goodwill and Intangible Assets — Goodwill represents the excess of the cost of acquired assets over the fair value of assets acquired. The Company operates in one reporting unit and in the fourth quarter of each year performs a quantitative assessment of its goodwill by comparing the Company's fair market value, or market capitalization, to the carrying value of the Company, including goodwill, to determine if impairment exists. Any excess of the carrying amount over fair value would be charged to impairment expense.
Income Taxes	Income Taxes — The Company accounts for income taxes using the liability method, under which deferred tax assets and liabilities are determined based on the future tax consequences attributable to differences between the financial reporting carrying amounts of existing assets and liabilities and their respective tax basis and tax credit carry forwards and net operating loss carryforwards. Deferred tax assets and liabilities are measured using the enacted tax rates that are expected to be in effect when the differences are expected to reverse. The Company assesses the likelihood that deferred tax assets will be recovered from future taxable income, and a valuation allowance is established when necessary to reduce deferred tax assets to the amounts more likely than not expected to be realized. In accordance with the guidance for accounting for uncertainty in income taxes the Company recognizes the tax benefits from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefit of an uncertain tax position that meets the more-likely-than-not recognition threshold is measured as the largest amount that is greater than 50% likely to be realized upon settlement with the tax authority. To the extent we prevail in matters for which accruals have been established or are required to pay amounts in excess of accruals, our effective tax rate in a given financial statement period could be affected.
Revenue Recognition and Accounts Receivable	Revenue Recognition and Accounts Receivable — The Company’s revenue is shown as “Net sales” in the accompanying Consolidated Statements of Operations and is measured as the determined transaction price, net of any variable consideration consisting primarily of rights to return product. The Company has elected to treat shipping and handling revenues as activities to fulfill its performance obligation. Billings for freight and shipping and handling are recorded in net sales and costs of freight and shipping and handling are recorded in cost of sales in the accompanying Consolidated Statements of Operations. The Company will record a contract liability in cases where customers pay in advance of the Company satisfying its performance obligation. The Company did not have any material unsatisfied performance obligations or liabilities as of December 31, 2022 and 2021. The Company offers customers rights to return product within a certain time, usually 30 days. The Company estimates its sales returns liability quarterly based upon its historical return rates as a percentage of historical sales for the trailing twelve-month period. The total accrued sales returns liability was approximately $2.2 million at December 31, 2022 and 2021, respectively, and was recorded as a refund liability in Accrued expenses and other current liabilities in the accompanying Consolidated Balance Sheets.
Allowance for Credit Losses	Allowance for Credit Losses — The Company’s trade accounts receivable is one portfolio comprised of commercial businesses and public sector organizations operating in the U.S. and to a much lesser extent, Canada. The Company develops its allowances for credit losses, which represent an estimate of expected losses over the remaining contractual life of its receivables, considering customer financial condition, historical loss experience with its customers, current market economic conditions and forecasts of future economic conditions when appropriate. When the Company becomes aware of a customer's inability to meet its financial obligation, a specific reserve is recorded to reduce the receivable to the expected amount to be collected. For the balance of its trade receivables, the Company uses a loss rate method to estimate its credit loss reserve. Historical loss experience rates are calculated using receivable write offs over a trailing twelve-month period and comparing that to the average receivable balances over the same period. That rate is applied to the current accounts receivable portfolio, excluding accounts that have been specifically reserved. Any write offs incurred are recorded against the established reserves. The Company grants credit to commercial business customers using an electronic application process that evaluates the customer's detailed credit report, reference responses, availability under credit facilities, existing liens, tenure of management and business history, among other factors. Credit terms are typically net 30 days payment required with larger businesses eligible for up to net 90 day terms, if qualified.
Shipping and Handling Costs	Shipping and Handling Costs — The Company recognizes shipping and handling costs in cost of sales.
Advertising Costs	Advertising Costs — Expenditures for internet, television, local radio and newspaper advertising are expensed in the period the advertising takes place. Catalog preparation, printing and postage expenditures are amortized over the fiscal year during which the benefits are expected.
Net Income Per Common Share	Net Income Per Common Share — Net income per common share - basic is calculated based upon the weighted average number of common shares outstanding during the respective periods presented using the two-class method of computing earnings per share. The two-class method was used as the Company has outstanding restricted stock with rights to dividend participation for unvested shares. Undistributed net income is allocated between common shares outstanding and participating securities to the extent that each security may share in earnings as if all of the earnings for the period had been distributed. Undistributed net losses are not allocated to our participating securities as these participating securities do not have a contractual obligation to share in losses. Net income per common share - diluted was calculated based upon the weighted average number of common shares outstanding and included the equivalent shares for dilutive options outstanding during the respective periods, including unvested options. The dilutive effect of outstanding options and restricted stock issued by the Company is reflected in net income per share - diluted using the treasury stock method. Under the treasury stock method, options will only have a dilutive effect when the average market price of common stock during the period exceeds the exercise price of the options.
Employee Benefit Plans	Employee Benefit Plans — The Company’s U.S. subsidiaries participate in a defined contribution 401(k) plan covering substantially all U.S. employees.  Employees may invest 1% or more of their eligible compensation, limited to maximum amounts as determined by the Internal Revenue Service. The Company provides a matching contribution to the plan, determined as a percentage of the employees’ contributions.
Fair Value Measurements	Fair Value Measurements — Fair value accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value standards establish the fair value hierarchy to prioritize the inputs used in valuation techniques. There are three levels to the fair value hierarchy (Level 1 is the highest priority and Level 3 is the lowest priority): Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 - Inputs other than quoted prices included in Level 1 that are observable for the asset or liability either directly or indirectly. Level 3 - Unobservable inputs which are supported by little or no market activity Financial instruments consist primarily of investments in cash, trade accounts receivable, debt and accounts payable. The Company determines the fair value of financial instruments based on interest rates available to the Company. At December 31, 2022 and 2021, the carrying amounts of cash, accounts receivable, outstanding debt and accounts payable are considered to be representative of their respective fair values due to their short-term nature. Cash is classified as Level 1 within the fair value hierarchy. The fair value of goodwill, non-amortizing intangibles and long-lived assets is measured in connection with the Company’s annual impairment testing as discussed above.
Significant Concentrations	Significant Concentrations — Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and accounts receivable. The Company’s excess cash balances are invested with money center banks. Concentrations of credit risk with respect to accounts receivable are limited due to the large number of customers and their
Recent Accounting Pronouncements	Recent Accounting Pronouncements Public companies in the United States are subject to the accounting and reporting requirements of various authorities, including the Financial Accounting Standards Board (“FASB”) and the Securities and Exchange Commission (“SEC”). These authorities issue numerous pronouncements, most of which are not applicable to the Company’s current or reasonably foreseeable operating structure. There were no accounting pronouncements issued in the year or with future effective dates that are either applicable nor are expected to have a material impact on the Company's Consolidated Financial Statements.

CREDIT LOSSES (Tables)

CREDIT LOSSES (Tables)	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Schedule of Allowance For Credit Losses On Trade Accounts Receivable	The following is a rollforward of the allowances for credit losses related to the Company's receivables for the year ended December 31, 2022 and 2021 (in millions): December 31, 2022 2021 Balance at beginning of period $ 2.5 $ 1.7 Current period provision 1.6 2.8 Write-offs - trade accounts receivable (1.8) (2.0) Balance at end of period $ 2.3 $ 2.5

LEASES (Tables)

LEASES (Tables)	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Summary of ROU Remaining Lease Term and Discount Rate	Information relating to operating leases for continuing and discontinued operations as of December 31, 2022 and, 2021: Year Ended December 31, 2022 2021 Weighted Average Remaining Lease Term Operating leases 8.2 years 8.1 years Weighted Average Discount Rate Operating leases 5.4 % 5.2 % ROU assets obtained in exchange for operating lease obligations $ 34.5 $ 2.6
Summary of Maturities of Lease Liabilities	Maturities of lease liabilities were as follows (in millions): Year Ending December 31 Operating Leases 2023 $ 17.7 2024 16.7 2025 15.7 2026 13.9 2027 11.7 Thereafter 52.5 Total lease payments 128.2 Less: interest (26.7) Total present value of lease liabilities $ 101.5

REVENUE (Tables)

REVENUE (Tables)	12 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table presents the Company's revenue, from continuing operations, by geography for the year ended December 31, 2022, 2021 and 2020 (in millions): Year Ended December 31, 2022 2021 2020 Net sales: United States 1,094.3 $ 993.9 $ 968.1 Canada 71.8 69.2 60.9 Consolidated $ 1,166.1 $ 1,063.1 $ 1,029.0

GOODWILL, INTANGIBLES AND OTH_2

GOODWILL, INTANGIBLES AND OTHER ASSETS (Tables)	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets, Goodwill and Other Assets	The following table provides information related to the carrying value of goodwill, intangibles (indefinite lived and definite lived) and other assets (in millions): December 31, 2022 2021 Goodwill $ 5.5 $ 5.5 Intangibles 1.1 1.3 Other assets 1.7 1.2 Balances, December 31 $ 8.3 $ 8.0
Schedule of Indefinite-Lived Intangible Assets	The following table provides information related to the carrying value of indefinite lived intangibles as of December 31, 2022 and 2021, respectively (in millions): December 31, 2022 2021 Balance, December 31 $ 0.7 $ 0.7
Schedule of Definite-Lived Intangible Assets	The following table summarizes information related to definite-lived intangible assets as of December 31, 2022 (in millions): December 31, 2022 Amortization Gross Carrying Accumulated Net Book Value Weighted avg Client lists 5-10 yrs $ 2.0 $ 1.6 $ 0.4 2.1 Domain name 5 yrs 3.4 3.4 0.0 0.0 Total $ 5.4 $ 5.0 $ 0.4 2.1 The following table summarizes information related to definite-lived intangible assets as of December 31, 2021 (in millions): December 31, 2021 Amortization Gross Carrying Accumulated Net Book Value Weighted avg Client lists 5-10 yrs $ 2.0 $ 1.4 $ 0.6 3.1 Domain name 5 yrs 3.4 3.4 0.0 0.0 Total $ 5.4 $ 4.8 $ 0.6 3.1
Schedule of Aggregate Amortization Expense for Intangibles	The aggregate amortization expense for these intangibles was approximately $0.2 million in 2022. The estimated amortization for future years ending December 31 is as follows (in millions): 2023 $ 0.2 2024 0.2 Total $ 0.4

DISCONTINUED OPERATIONS (Tables

DISCONTINUED OPERATIONS (Tables)	12 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Exit Costs	The following table details liabilities related to the exit costs of the sold businesses that remain for 2022 (in millions): Accrued exit costs Balance January 1, 2022 $ 2.7 Charged to expense 0.1 Paid or otherwise settled (0.4) Balance December 31, 2022 $ 2.4 The following table details liabilities related to the exit costs of the sold businesses for 2021 (in millions): Accrued exit costs Balance, January 1, 2021 $ 2.8 Charged to expense 0.4 Paid or otherwise settled (0.5) Balance, December 31, 2021 $ 2.7

PROPERTY, PLANT AND EQUIPMENT (

PROPERTY, PLANT AND EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment, Net	Property, plant and equipment, net consist of the following (in millions): December 31, 2022 2021 Land improvements $ 0.8 $ 0.8 Furniture and fixtures, office, computer and other equipment and software 42.4 37.8 Leasehold improvements 14.2 13.5 57.4 52.1 Less accumulated depreciation and amortization 36.4 35.6 Property, plant and equipment, net $ 21.0 $ 16.5

ACCRUED EXPENSES AND OTHER CU_2

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2022
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consist of the following (in millions): December 31, 2022 2021 Payroll and employee benefits $ 22.5 $ 22.3 Sales and VAT tax payable 2.9 2.8 Freight 7.7 11.4 Income taxes payable 0.0 4.9 Product returns liability 2.2 2.2 Other 7.9 6.9 $ 43.2 $ 50.5

NET INCOME PER COMMON SHARE (Ta

NET INCOME PER COMMON SHARE (Tables)	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table presents the computation of basic and diluted net income per share under the two-class method for the year ended December 31, 2022, 2021 ad 2020 (in millions, except for per share amounts): Year Ended December 31, 2022 2021 2020 Net income from continuing operations $ 78.1 $ 70.1 $ 64.1 Less: Distributed net income available to participating securities (0.1) (0.3) (0.8) Less: Undistributed net income available to participating securities (0.2) 0.0 0.0 Numerator for basic net income per share: Undistributed and distributed net income available to common shareholders $ 77.8 $ 69.8 $ 63.3 Add: Undistributed net income allocated to participating securities 0.2 0.0 0.0 Less: Undistributed net income reallocated to participating securities (0.2) 0.0 0.0 Numerator for diluted net income per share: Undistributed and distributed net income available to common shareholders $ 77.8 $ 69.8 $ 63.3 Denominator: Weighted average shares outstanding for basic net income per share 38.0 37.8 37.5 Effect of dilutive securities 0.1 0.2 0.2 Weighted average shares outstanding for diluted net income per share 38.1 38.0 37.7 Net income per share from continuing operations: Basic $ 2.05 $ 1.85 $ 1.69 Diluted $ 2.04 $ 1.84 $ 1.68 Net income from discontinued operations $ 0.7 $ 33.2 $ 1.3 Less: Distributed net income available to participating securities $ 0.0 $ 0.0 $ 0.0 Less: Undistributed net income available to participating securities $ 0.0 $ (0.2) $ 0.0 Numerator for basic net income per share: Undistributed and distributed net income available to common shareholders $ 0.7 $ 33.0 $ 1.3 Add: Undistributed net income allocated to participating securities $ 0.0 $ 0.2 $ 0.0 Less: Undistributed net income reallocated to participating securities $ 0.0 $ (0.2) $ 0.0 Numerator for diluted net income per share: Undistributed and distributed net income available to common shareholders $ 0.7 $ 33.0 $ 1.3 Net income per share from discontinued operations: Basic $ 0.02 $ 0.88 $ 0.03 Diluted $ 0.02 $ 0.87 $ 0.03 Net income per share: Basic $ 2.07 $ 2.73 $ 1.72 Diluted $ 2.06 $ 2.71 $ 1.71 Potentially dilutive securities 0.1 0.1 0.5

SHAREHOLDERS' EQUITY (Tables)

SHAREHOLDERS' EQUITY (Tables)	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Weighted-Average Assumptions Used To Estimate the Fair Value of Options Granted	The following table presents the weighted-average assumptions used to estimate the fair value of options granted in 2022, 2021 and 2020: 2022 2021 2020 Expected annual dividend yield 2.0 % 1.4 % 2.0 % Risk-free interest rate 1.85 % 0.75 % 1.38 % Expected volatility 52.8 % 51.9 % 51.1 % Expected life in years 5.0 5.0 5.2
Schedule of Outstanding and Exercisable Options	The following table summarizes information concerning outstanding and exercisable options: Weighted Average 2022 2021 2020 Shares Weighted Shares Weighted Shares Weighted Outstanding at beginning of year 463,304 $ 24.28 661,024 $ 19.78 764,784 $ 17.31 Granted 79,025 $ 32.65 110,112 $ 38.02 111,872 $ 23.60 Exercised (29,917) $ 22.87 (196,639) $ 15.37 (191,780) $ 11.68 Canceled or expired (3,200) $ 26.61 (111,193) $ 26.87 (23,852) $ 23.71 Outstanding at end of year 509,212 $ 25.65 463,304 $ 24.28 661,024 $ 19.78 Options exercisable at year end 297,889 223,158 302,283 Weighted average fair value per option granted during the year $ 13.07 $ 18.50 $ 9.12
Schedule of Options Vested and Exercisable or Nonvested, Expected to Vest (Nonvested Outstanding Less Expected Forfeitures)	The following table summarizes information about options vested and exercisable or non-vested that are expected to vest (non-vested outstanding less expected forfeitures) at December 31, 2022: Range of Exercise Prices Options Outstanding and Weighted Weighted Average Aggregate $ 5.00 to $ 15.00 47,500 $ 5.92 3.65 $ 0.8 $ 15.01 to $ 25.00 319,572 $ 23.55 6.19 0.1 $ 25.01 to $ 35.00 87,439 $ 32.75 9.05 0.0 $ 35.01 to $ 45.00 54,701 $ 43.68 8.23 0.0 $ 5.00 to $ 45.00 509,212 $ 25.65 6.67 $ 0.9
Schedule of Unvested Stock Options	The following table reflects the activity for all unvested stock options during 2022: Shares Weighted Unvested at January 1, 2022 240,146 $ 12.80 Granted 79,025 $ 13.07 Vested (104,711) $ 11.26 Forfeited (3,137) $ 26.26 Unvested at December 31, 2022 211,323 $ 12.84
Restricted Stock Award Activity	The following table reflects the activity for restricted stock awards, excluding the restricted stock issued to Directors (in millions, except shares data): Year Granted Shares Granted Outstanding at December 31, 2022 Rights to Cash Dividend Other Participation Rights Performance Award Compensation Expense Year Ended December 31, 2022 2021 2020 2019 30,251 12,100 Yes None No 0.1 0.1 0.2 2019 149,412 0 Yes None Yes 0.3 0.1 1.2 2020 28,272 14,136 Yes None No 0.1 0.2 0.4 2020 43,330 4,087 Yes None Yes 0.1 0.1 0.6 2021 25,371 19,028 Yes None No 0.3 0.4 0.0 2021 32,874 9,795 Yes None Yes 0.2 0.3 0.0 2022 60,808 54,807 Yes None No 0.8 0.0 0.0 2022 32,875 23,360 Yes None Yes 0.6 0.0 0.0 Total $ 2.5 $ 1.2 $ 2.4
Nonvested Restricted Stock Shares Activity	The following table reflects the activity for all unvested restricted stock during 2022: Shares Weighted Unvested at January 1, 2022 135,446 $ 28.48 Granted 99,679 $ 34.14 Vested (84,483) $ 26.79 Forfeited (1,417) $ 26.10 Unvested at December 31, 2022 149,225 $ 33.24

INCOME TAX (Tables)

INCOME TAX (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of Components of Income (Loss) before Income Taxes	The following table summarizes our U.S. and foreign components of income from continuing operations before income taxes (in millions): Year Ended December 31, 2022 2021 2020 United States $ 104.0 $ 84.5 $ 80.5 Foreign (0.2) 3.1 3.5 Total $ 103.8 $ 87.6 $ 84.0
Schedule of (Benefit) Provision for Income Taxes	The following table summarizes the (benefit) provision for income taxes from continuing operations (in millions): Year Ended December 31, 2022 2021 2020 Current: Federal $ 21.2 $ 16.8 $ 17.0 State 4.3 3.8 3.3 Foreign 0.2 0.1 0.1 Total current $ 25.7 $ 20.7 $ 20.4 Deferred: Federal $ 0.0 $ (0.6) $ (0.8) State 0.1 (0.2) 0.3 Foreign (0.1) (2.4) 0.0 Total deferred $ 0.0 $ (3.2) $ (0.5) Total tax provision $ 25.7 $ 17.5 $ 19.9
Schedule of Reconciliation of Difference between Income Tax Expense and Computed Income Tax Expense Based on Federal Statutory Corporate Rate	A reconciliation of the difference between the income tax expense and the computed income tax expense from continuing operations based on the Federal statutory corporate rate is as follows (in millions): Year Ended December 31, 2022 2021 2020 Income tax at Federal statutory rate $ 21.8 21.0 % $ 18.4 21.0 % $ 17.6 21.0 % State and local income taxes, net of federal tax benefit 3.7 3.7 % 2.9 3.3 % 3.0 3.5 % Reversal of valuation allowances 0.0 0.0 % (3.4) (3.8) % (0.9) (1.0) % 2017 TCJA, net deferred tax remeasurement and repatriation tax impacts (0.2) (0.1) % 0.0 0.0 % 0.0 0.0 % Stock based compensation 0.0 0.0 % (0.8) (0.9) % (0.5) (0.6) % Non-deductible items 0.7 0.6 % 0.5 0.5 % 0.8 0.9 % Other items, net (0.3) (0.4) % (0.1) (0.1) % (0.1) (0.1) % Income tax $ 25.7 24.8 % $ 17.5 20.0 % $ 19.9 23.7 %
Schedule of Deferred Tax Assets and Liabilities	The deferred tax assets and liabilities are comprised of the following (in millions): December 31, 2022 2021 Assets: Accrued expenses and other liabilities $ 1.6 $ 2.4 Inventory 2.9 2.8 Operating lease obligations 25.3 18.8 Intangible & other 0.4 0.0 Net operating loss and credit carryforwards 8.1 8.8 Valuation allowances (5.8) (6.1) Total deferred tax assets $ 32.5 $ 26.7 Liabilities: Operating lease right-of-use assets $ 22.6 $ 16.4 Other 0.1 0.2 Total deferred tax liabilities $ 22.7 $ 16.6
Summary of Valuation Allowance	The following table summarizes the changes in valuation allowance (in millions): Balance at Benefit Recognized in Expense Write-offs Other Balance at 2022 $ (6.1) $ 0.0 $ 0.3 $ 0.0 $ (5.8) 2021 $ (15.2) $ 3.0 $ 7.0 $ (0.9) $ (6.1)

BASIS OF PRESENTATION (Details)

BASIS OF PRESENTATION (Details) product in Millions, $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2021 USD ($)	Dec. 31, 2022 USD ($) segment product	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of products distributed (more than) | product		1
Number of reportable segments (in segments) | segment		1
Income from discontinued operations, net of tax		$ 0.7	$ 33.2	$ 1.3
Immediate Family Member of Management or Principal Owner
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Professional fees		0	3.1
Inventory Purchases | Immediate Family Member of Management or Principal Owner
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchases from related party				3.2
Disposed of by Sale | NATG
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Income from discontinued operations, net of tax	$ 22.7	$ 0.7	$ 33.2	$ 1.3

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) supplier	Dec. 31, 2021 USD ($) supplier	Dec. 31, 2020 USD ($) supplier
Property, Plant and Equipment [Line Items]
Disposals of property plant and equipment	$ 3	$ 1.7
Accumulated depreciation on disposals	2.9	1.7
Restricted cash	0	0	$ 1.6
Restricted Cash [Abstract]
Restricted cash	0	0	1.6
Cash collateralizing letters of credit outstanding			1.6
Revenues [Abstract]
Performance obligation	0	0
Accrued sales returns	2.2	2.2
Advertising Costs
Advertising expense	$ 72	65.3	60.3
Employee Benefit Plans
Minimum annual contribution per employee	1%
Aggregate expense in contribution plans	$ 1.5	$ 1.4	$ 1.4
Fair Value Measurements
Weighted average interest rate on short-term borrowings	4.40%	4.30%	4.40%
Significant Concentrations
Number of suppliers (in suppliers) | supplier	0	0	0
Minimum | Furniture, Fixtures and Equipment
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years
Maximum | Furniture, Fixtures and Equipment
Property, Plant and Equipment [Line Items]
Estimated useful lives	15 years

CREDIT LOSSES (Details)

CREDIT LOSSES (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Allowance for Credit Loss [Roll Forward]
Balance at beginning of period	$ 2.5	$ 1.7
Current period provision	1.6	2.8
Write-offs - trade accounts receivable	(1.8)	(2)
Balance at end of period	$ 2.3	$ 2.5

LEASES - Narrative (Details)

LEASES - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating lease cost	$ 15.4	$ 13.9	$ 13.1
Rent expenses from transaction with related party	1	1	1
Sublease income	2.7	$ 1.3	$ 1.7
Sublease agreements less then one year	2.5
Sublease agreements between one and three years	5.1
Sublease agreements between three and five years	$ 0.8

LEASES - Lease Expense (Details

LEASES - Lease Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating leases, weighted average remaining lease term (years)	8 years 2 months 12 days	8 years 1 month 6 days
Operating leases, weighted average discount rate (percent)	5.40%	5.20%
ROU assets obtained in exchange for operating lease obligations	$ 34.5	$ 2.6	$ 28.7

LEASES - Maturities of Lease Li

LEASES - Maturities of Lease Liabilities (Details) $ in Millions	Dec. 31, 2022 USD ($)
Leases [Abstract]
2023	$ 17.7
2024	16.7
2025	15.7
2026	13.9
2027	11.7
Thereafter	52.5
Total lease payments	128.2
Less: interest	(26.7)
Total present value of lease liabilities	$ 101.5

REVENUE (Details)

REVENUE (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Net sales	$ 1,166.1	$ 1,063.1	$ 1,029
Reportable Geographical Components | United States
Disaggregation of Revenue [Line Items]
Net sales	1,094.3	993.9	968.1
Reportable Geographical Components | Canada
Disaggregation of Revenue [Line Items]
Net sales	$ 71.8	$ 69.2	$ 60.9

GOODWILL, INTANGIBLES AND OTH_3

GOODWILL, INTANGIBLES AND OTHER ASSETS - Goodwill, Intangibles (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 5.5	$ 5.5
Intangibles	1.1	1.3
Other assets	1.7	1.2
Goodwill, intangibles and other assets	$ 8.3	$ 8

GOODWILL, INTANGIBLES AND OTH_4

GOODWILL, INTANGIBLES AND OTHER ASSETS - Indefinite-Lived Intangible Assets (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Indefinite-lived intangible assets	$ 0.7	$ 0.7

GOODWILL, INTANGIBLES AND OTH_5

GOODWILL, INTANGIBLES AND OTHER ASSETS - Definite-Lived Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 5.4	$ 5.4
Accumulated Amortization	5	4.8
Net Book Value	$ 0.4	$ 0.6
Weighted avg useful life	2 years 1 month 6 days	3 years 1 month 6 days
Client lists
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 2	$ 2
Accumulated Amortization	1.6	1.4
Net Book Value	$ 0.4	$ 0.6
Weighted avg useful life	2 years 1 month 6 days	3 years 1 month 6 days
Client lists | Minimum Years
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	5 years	5 years
Client lists | Maximum Years
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	10 years	10 years
Domain name
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	5 years	5 years
Gross Carrying Amount	$ 3.4	$ 3.4
Accumulated Amortization	3.4	3.4
Net Book Value	$ 0	$ 0
Weighted avg useful life	0 years	0 years

GOODWILL, INTANGIBLES AND OTH_6

GOODWILL, INTANGIBLES AND OTHER ASSETS - Schedule of Amortization Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 0.2
2023	0.2
2024	0.2
Net Book Value	$ 0.4	$ 0.6

DISCONTINUED OPERATIONS - Narra

DISCONTINUED OPERATIONS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Income from discontinued operations, net of tax		$ 0.7	$ 33.2	$ 1.3
Disposed of by Sale | NATG
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Income from discontinued operations, net of tax	$ 22.7	0.7	33.2	1.3
Restitution receipts		(0.7)	(15)	(1.9)
Ongoing restitution proceedings		0.4	3	0.5
Resolution of certain liabilities		0.5
Income (loss) from discontinued operation, before income tax			31.7
Tax effect of discontinued operation expense (benefit)		0.2	$ 10.7	$ 0.5
Discontinued operations | NATG
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Additional exit costs, expected future charges		$ 0.5

DISCONTINUED OPERATIONS - Sched

DISCONTINUED OPERATIONS - Schedule of Exit Costs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Restructuring Reserve [Roll Forward]
Balance beginning of period	$ 2.7	$ 2.8
Charged to expense	0.1	0.4
Paid or otherwise settled	(0.4)	(0.5)
Balance end of period	$ 2.4	$ 2.7

PROPERTY, PLANT AND EQUIPMENT -

PROPERTY, PLANT AND EQUIPMENT - Schedule of Property, Plant, and Equipment (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 57.4	$ 52.1
Less accumulated depreciation and amortization	36.4	35.6
Property, plant and equipment, net	21	16.5
Land improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	0.8	0.8
Furniture and fixtures, office, computer and other equipment and software
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	42.4	37.8
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 14.2	$ 13.5

PROPERTY, PLANT AND EQUIPMENT_2

PROPERTY, PLANT AND EQUIPMENT - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Depreciation	$ 3.7	$ 3.5	$ 3.9
Disposals of property plant and equipment	3	1.7
Accumulated depreciation on disposals	$ 2.9	$ 1.7

CREDIT FACILITIES AND SHORT-T_2

CREDIT FACILITIES AND SHORT-TERM DEBT (Details)	12 Months Ended
	Dec. 31, 2022 USD ($) financialInstitution	Nov. 30, 2022 USD ($)
Line of Credit Facility [Line Items]
Cash collateralizing letters of credit outstanding	$ 1,400,000
Revolving Credit Facility
Line of Credit Facility [Line Items]
Existing current borrowing capacity	113,700,000	$ 75,000,000
Maximum borrowing capacity	$ 116,400,000	125,000,000
Number of financial institutions (in financial institutions) | financialInstitution	1
Term of credit facility	5 years
Amended inventory advance rate	65%
Existing inventory advance rate	60%
Percentage of inventory advance rate of net orderly liquidation value	85%
Total availability under the credit facility	$ 113,700,000	$ 75,000,000
Short term debt borrowing	600,000
Excess availability under line of credit	$ 111,700,000
Revolving Credit Facility | Maximum
Line of Credit Facility [Line Items]
Percentage of eligible accounts receivable for borrowings	85%

ACCRUED EXPENSES AND OTHER CU_3

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Payables and Accruals [Abstract]
Payroll and employee benefits	$ 22.5	$ 22.3
Sales and VAT tax payable	2.9	2.8
Freight	7.7	11.4
Income taxes payable	0	4.9
Product returns liability	2.2	2.2
Other	7.9	6.9
Accrued expenses	$ 43.2	$ 50.5

NET INCOME PER COMMON SHARE - S

NET INCOME PER COMMON SHARE - Schedule of Net Income (loss) per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net income from continuing operations	$ 78.1	$ 70.1	$ 64.1
Less: Distributed net income available to participating securities	(0.1)	(0.3)	(0.8)
Less: Undistributed net income available to participating securities	(0.2)	0	0
Numerator for basic net income per share:
Undistributed and distributed net income available to common shareholders	77.8	69.8	63.3
Add: Undistributed net income allocated to participating securities	0.2	0	0
Less: Undistributed net income reallocated to participating securities	(0.2)	0	0
Numerator for diluted net income per share:
Undistributed and distributed net income available to common shareholders	$ 77.8	$ 69.8	$ 63.3
Denominator:
Weighted average shares outstanding for basic net income per share (in shares)	38	37.8	37.5
Effect of dilutive securities (in shares)	0.1	0.2	0.2
Weighted average shares outstanding for diluted net income per share (in shares)	38.1	38	37.7
Net income per share from continuing operations:
Basic (in dollars per share)	$ 2.05	$ 1.85	$ 1.69
Diluted (in dollars per share)	$ 2.04	$ 1.84	$ 1.68
Net income per common share from discontinued operations:
Less: Distributed net income available to participating securities	$ (0.1)	$ (0.3)	$ (0.8)
Numerator for diluted net income per share:
Undistributed and distributed net income available to common shareholders	$ 77.8	$ 69.8	$ 63.3
Net income per share from discontinued operations:
Basic (in dollars per share)	$ 0.02	$ 0.88	$ 0.03
Diluted (in dollars per share)	0.02	0.87	0.03
Net income per share - Basic (in dollars per share)	2.07	2.73	1.72
Net income per share - Diluted (in dollars per share)	$ 2.06	$ 2.71	$ 1.71
Potentially dilutive securities (in shares)	0.1	0.1	0.5
Discontinued operations
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Less: Distributed net income available to participating securities	$ 0	$ 0	$ 0
Numerator for diluted net income per share:
Undistributed and distributed net income available to common shareholders	0.7	33	1.3
Net income per common share from discontinued operations:
Net income from discontinued operations	0.7	33.2	1.3
Less: Distributed net income available to participating securities	0	0	0
Less: Undistributed net income available to participating securities	0	(0.2)	0
Numerator for basic net income per share:
Undistributed and distributed net income available to common shareholders	0.7	33	1.3
Add: Undistributed net income allocated to participating securities	0	0.2	0
Less: Undistributed net income reallocated to participating securities	0	(0.2)	0
Numerator for diluted net income per share:
Undistributed and distributed net income available to common shareholders	$ 0.7	$ 33	$ 1.3

STOCK REPURCHASES (Details)

STOCK REPURCHASES (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2018
Equity [Abstract]
Number of shares authorized to be repurchased (in shares)				2,000,000
Purchase of treasury shares (in shares)	0	0	392,337
Shares repurchased, value	$ 0	$ 0	$ 7.2
Maximum number of shares that may yet be purchased under the plans or programs (in shares)	1,375,000

SHAREHOLDERS' EQUITY - Narrativ

SHAREHOLDERS' EQUITY - Narrative (Details) $ / shares in Units, $ in Millions	1 Months Ended	12 Months Ended
	Dec. 31, 2018 shares	Dec. 31, 2022 USD ($) plan $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) $ / shares shares	Dec. 31, 2019 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of compensation plans (in plans) | plan		2
Share based compensation cost | $		$ 4.5	$ 2.9	$ 4.7
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options outstanding (in shares)		509,212	463,304	661,024	764,784
Share based compensation cost | $		$ 1.3	$ 1.1	$ 1.8
Share based compensation cost, future income tax benefits | $		0.2	0.3	0.4
Total intrinsic value of options exercised | $		0.3	4.5	3.9
Unrecognized compensation costs, unvested stock options | $		$ 1.1
Weighted average period of recognition (years)		2 years 10 months 17 days
Total fair value of stock options vested | $		$ 1.3	1.2	2.5
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average period of recognition (years)		2 years 10 months 17 days
Unrecognized compensation cost | $		$ 2.5
Restricted Stock Units (RSUs) | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)		5,996
Restricted Stock Units (RSUs) | Director | Selling, Distribution and Administrative Expenses
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation cost | $		$ 0.2	0.2	0.2
2010 Long-term Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period (years)		10 years
Number of shares authorized for issuance (in shares)		7,500,000
2010 Long-term Stock Incentive Plan | Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options outstanding (in shares)		339,856
2010 Long-term Stock Incentive Plan | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock outstanding (in shares)		30,323
2010 Long-term Stock Incentive Plan | Stock Option and Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted per calendar year in total, maximum (in shares)		1,500,000
2020 Omnibus Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period (years)		10 years
Number of shares authorized for issuance (in shares)		7,500,000
Cash performance awards | $		$ 10
2020 Omnibus Stock Incentive Plan | Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted per calendar year in total, maximum (in shares)		1,500,000
Number of options outstanding (in shares)		169,356
2020 Omnibus Stock Incentive Plan | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock outstanding (in shares)		118,902
2020 Omnibus Stock Incentive Plan | Restricted Stock Units (RSUs) | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock outstanding (in shares)		11,912
2018 Employee Stock Purchase Plan | Employee Stock Option | Selling, Distribution and Administrative Expenses
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation Expense | $		$ 0.5	$ 0.4	$ 0.3
2018 Employee Stock Purchase Plan | Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for issuance (in shares)	500,000	297,753
Stock plan offering period (months)	6 months
Employee stock purchase plan, maximum shares available to purchase (in shares)	10,000
Employee stock purchase plan, purchase price of stock, percent	85%
Stock issued during period under ESPP (in shares)		53,143	55,248	49,627
Average purchase price of shares issues under ESPP (USD per share) | $ / shares		$ 26.16	$ 20.09	$ 16.85
Continuing Operations | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation cost | $		$ 2.7	$ 1.4	$ 2.5

SHAREHOLDERS' EQUITY - Weighted

SHAREHOLDERS' EQUITY - Weighted-Average Assumptions Used to Estimate Fair Value of Options (Details) - Employee Stock Option	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected annual dividend yield	2%	1.40%	2%
Risk-free interest rate	1.85%	0.75%	1.38%
Expected volatility	52.80%	51.90%	51.10%
Expected life in years	5 years	5 years	5 years 2 months 12 days

SHAREHOLDERS' EQUITY - Options

SHAREHOLDERS' EQUITY - Options Outstanding and Exercisable (Details) - Employee Stock Option - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Shares
Outstanding at beginning of year (in shares)	463,304	661,024	764,784
Granted (in shares)	79,025	110,112	111,872
Exercised (in shares)	(29,917)	(196,639)	(191,780)
Cancelled or expired (in shares)	(3,200)	(111,193)	(23,852)
Outstanding at end of year (in shares)	509,212	463,304	661,024
Options exercisable at year end (in shares)	297,889	223,158	302,283
Weighted Avg. Exercise Price
Outstanding at beginning of year (in dollars per share)	$ 24.28	$ 19.78	$ 17.31
Granted (in dollars per share)	32.65	38.02	23.60
Exercised (in dollars per share)	22.87	15.37	11.68
Cancelled or expired (in dollars per share)	26.61	26.87	23.71
Outstanding at end of year (in dollars per share)	25.65	24.28	19.78
Weighted average fair value per option granted during the year (in dollars per share)	$ 13.07	$ 18.50	$ 9.12

SHAREHOLDERS' EQUITY - Option_2

SHAREHOLDERS' EQUITY - Options Vested and Exercisable or Nonvested that are Expected to Vest (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares
5.00 to 15.00
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Lower Range Limit (in dollars per share)	$ 5
Range of Exercise Prices, Upper Range Limit (in dollars per share)	$ 15
Options Outstanding and Exercisable (in shares) | shares	47,500
Weighted Average Exercise Price (in dollars per share)	$ 5.92
Weighted Average Remaining Contractual Life	3 years 7 months 24 days
Aggregate Intrinsic Value (in millions) | $	$ 0.8
15.01 to 25.00
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Lower Range Limit (in dollars per share)	$ 15.01
Range of Exercise Prices, Upper Range Limit (in dollars per share)	$ 25
Options Outstanding and Exercisable (in shares) | shares	319,572
Weighted Average Exercise Price (in dollars per share)	$ 23.55
Weighted Average Remaining Contractual Life	6 years 2 months 8 days
Aggregate Intrinsic Value (in millions) | $	$ 0.1
25.01 to 35.00
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Lower Range Limit (in dollars per share)	$ 25.01
Range of Exercise Prices, Upper Range Limit (in dollars per share)	$ 35
Options Outstanding and Exercisable (in shares) | shares	87,439
Weighted Average Exercise Price (in dollars per share)	$ 32.75
Weighted Average Remaining Contractual Life	9 years 18 days
Aggregate Intrinsic Value (in millions) | $	$ 0
35.01 to 45.00
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Lower Range Limit (in dollars per share)	$ 35.01
Range of Exercise Prices, Upper Range Limit (in dollars per share)	$ 45
Options Outstanding and Exercisable (in shares) | shares	54,701
Weighted Average Exercise Price (in dollars per share)	$ 43.68
Weighted Average Remaining Contractual Life	8 years 2 months 23 days
Aggregate Intrinsic Value (in millions) | $	$ 0
5.00 to 45.00
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Lower Range Limit (in dollars per share)	$ 5
Range of Exercise Prices, Upper Range Limit (in dollars per share)	$ 45
Options Outstanding and Exercisable (in shares) | shares	509,212
Weighted Average Exercise Price (in dollars per share)	$ 25.65
Weighted Average Remaining Contractual Life	6 years 8 months 1 day
Aggregate Intrinsic Value (in millions) | $	$ 0.9

SHAREHOLDERS' EQUITY - Unvested

SHAREHOLDERS' EQUITY - Unvested Stock Options (Details) - Unvested Stock Options	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Shares
Unvested at beginning of the year (in shares) | shares	240,146
Granted (in shares) | shares	79,025
Vested (in shares) | shares	(104,711)
Forfeited (in shares) | shares	(3,137)
Unvested at end of the year (in shares) | shares	211,323
Weighted Average Grant- Date Fair Value
Unvested at the beginning of the year (in dollars per share) | $ / shares	$ 12.80
Granted (in dollars per share) | $ / shares	13.07
Vested (in dollars per share) | $ / shares	11.26
Forfeited (in dollars per share) | $ / shares	26.26
Unvested at the end of the year (in dollars per share) | $ / shares	$ 12.84

SHAREHOLDERS' EQUITY - Restrict

SHAREHOLDERS' EQUITY - Restricted Stock Awards (Details) - Restricted Stock - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock granted (in shares)	99,679
2010 Long-term Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation Expense	$ 2.5	$ 1.2	$ 2.4
2010 Long-term Stock Incentive Plan | 2019 Non-Performance Award
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock granted (in shares)				30,251
Restricted stock outstanding (in shares)	12,100
Compensation Expense	$ 0.1	0.1	0.2
2010 Long-term Stock Incentive Plan | 2019 Performance Award
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock granted (in shares)				149,412
Restricted stock outstanding (in shares)	0
Compensation Expense	$ 0.3	0.1	$ 1.2
2010 Long-term Stock Incentive Plan | 2020 Non-Performance Award
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock granted (in shares)			28,272
Restricted stock outstanding (in shares)	14,136
Compensation Expense	$ 0.1	0.2	$ 0.4
2010 Long-term Stock Incentive Plan | 2020 Performance Award
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock granted (in shares)			43,330
Restricted stock outstanding (in shares)	4,087
Compensation Expense	$ 0.1	$ 0.1	$ 0.6
2020 Omnibus Stock Incentive Plan | 2021 Non-Performance Award
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock granted (in shares)		25,371
Restricted stock outstanding (in shares)	19,028
Compensation Expense	$ 0.3	$ 0.4	0
2020 Omnibus Stock Incentive Plan | 2021 Performance Award
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock granted (in shares)		32,874
Restricted stock outstanding (in shares)	9,795
Compensation Expense	$ 0.2	$ 0.3	0
2020 Omnibus Stock Incentive Plan | 2022 Non-Performance Award
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock granted (in shares)	60,808
Restricted stock outstanding (in shares)	54,807
Compensation Expense	$ 0.8	0	0
2020 Omnibus Stock Incentive Plan | 2022 Performance Award
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock granted (in shares)	32,875
Restricted stock outstanding (in shares)	23,360
Compensation Expense	$ 0.6	$ 0	$ 0

SHAREHOLDERS' EQUITY - Unvest_2

SHAREHOLDERS' EQUITY - Unvested Restricted Stock (Details) - Restricted Stock	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Shares
Unvested at beginning of the year (in shares) | shares	135,446
Granted (in shares) | shares	99,679
Vested (in shares) | shares	(84,483)
Forfeited (in shares) | shares	(1,417)
Unvested at end of the year (in shares) | shares	149,225
Weighted Average Grant- Date Fair Value
Unvested at the beginning of the year (in dollars per share) | $ / shares	$ 28.48
Granted (in dollars per share) | $ / shares	34.14
Vested (in dollars per share) | $ / shares	26.79
Forfeited (in dollars per share) | $ / shares	26.10
Unvested at the end of the year (in dollars per share) | $ / shares	$ 33.24

INCOME TAX - Income (Loss) from

INCOME TAX - Income (Loss) from Continuing Operations Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
United States	$ 104	$ 84.5	$ 80.5
Foreign	(0.2)	3.1	3.5
Income from continuing operations before income taxes	$ 103.8	$ 87.6	$ 84

INCOME TAX - (Benefit) Provisio

INCOME TAX - (Benefit) Provision for Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current:
Federal	$ 21.2	$ 16.8	$ 17
State	4.3	3.8	3.3
Foreign	0.2	0.1	0.1
Total current	25.7	20.7	20.4
Deferred:
Federal	0	(0.6)	(0.8)
State	0.1	(0.2)	0.3
Foreign	(0.1)	(2.4)	0
Total deferred	0	(3.2)	(0.5)
Income tax	$ 25.7	$ 17.5	$ 19.9

INCOME TAX - Narrative (Details

INCOME TAX - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Valuation Allowance [Line Items]
Tax expense from discontinued operations	$ 200,000	$ 10,700,000	$ 500,000
Deferred tax assets, valuation allowance	5,800,000	6,100,000
Undistributed earnings of its foreign subsidiaries	400,000
Uncertain tax positions	0
Unrecognized tax benefits, accrued interest and penalties	0	$ 0	$ 0
State
Valuation Allowance [Line Items]
Operating loss carryforwards utilized in period	400,000
Foreign
Valuation Allowance [Line Items]
Net operating loss and foreign tax credit	6,900,000
Tax credit carryforward	600,000
Net operating loss carryforwards, valuation allowance	5,200,000
Tax credit carryforward, valuation allowance	$ 600,000

INCOME TAX - Reconciliation Bet

INCOME TAX - Reconciliation Between Income Tax Expense and Computed Income Tax Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Effective Income Tax Rate Reconciliation, Amount [Abstract]
Income tax at Federal statutory rate	$ 21.8	$ 18.4	$ 17.6
State and local income taxes, net of federal tax benefit	3.7	2.9	3
Reversal of valuation allowances	0	(3.4)	(0.9)
2017 TCJA, net deferred tax remeasurement and repatriation tax impacts	(0.2)	0	0
Stock based compensation	0	(0.8)	(0.5)
Non-deductible items	0.7	0.5	0.8
Other items, net	(0.3)	(0.1)	(0.1)
Income tax	$ 25.7	$ 17.5	$ 19.9
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Income tax at Federal statutory rate	21%	21%	21%
State and local income taxes, net of federal tax benefit	3.70%	3.30%	3.50%
Reversal of valuation allowances	0%	(3.80%)	(1.00%)
2017 TCJA, net deferred tax remeasurement and repatriation tax impacts	(0.001)	0	0
Stock based compensation	0%	(0.90%)	(0.60%)
Non-deductible items	0.60%	0.50%	0.90%
Other items, net	(0.40%)	(0.10%)	(0.10%)
Income tax	24.80%	20%	23.70%

INCOME TAX - Deferred Tax Asset

INCOME TAX - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Accrued expenses and other liabilities	$ 1.6	$ 2.4
Inventory	2.9	2.8
Operating lease obligations	25.3	18.8
Intangible & other	0.4	0
Net operating loss and credit carryforwards	8.1	8.8
Valuation allowances	(5.8)	(6.1)
Total deferred tax assets	32.5	26.7
Operating lease right-of-use assets	22.6	16.4
Other	0.1	0.2
Total deferred tax liabilities	$ 22.7	$ 16.6

INCOME TAX - Allowance for Defe

INCOME TAX - Allowance for Deferred Tax Assets (Details) - SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	$ (6.1)	$ (15.2)
Benefit Recognized in Expense	0	3
Write-offs	0.3	7
Other	0	(0.9)
Balance at End of Period	$ (5.8)	$ (6.1)